###begin article-title 0
Placenta-specific Methylation of the Vitamin D 24-Hydroxylase Gene
###end article-title 0
###begin p 1
###xml 13 27 13 27 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Wellcome Trust</grant-sponsor>
###xml 34 40 34 40 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">084071</grant-num>
Supported by Wellcome Trust Grant 084071.
###end p 1
###begin p 2
###xml 13 78 13 78 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">National Health and Medical Research Council Research Fellowships</grant-sponsor>
Supported by National Health and Medical Research Council Research Fellowships.
###end p 2
###begin p 3
###xml 167 194 167 194 <email xmlns:xlink="http://www.w3.org/1999/xlink">richard.saffery@mcri.edu.au</email>
 To whom correspondence should be addressed: Murdoch Childrens Research Institute, Flemington Road, Parkville, Victoria 3052, Australia. Tel.: 61-03-83416341; E-mail: richard.saffery@mcri.edu.au.
###end p 3
###begin p 4
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice
###end p 4
###begin p 5
 applies to Author Choice Articles
###end p 5
###begin p 6
###xml 65 66 65 66 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 145 152 141 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP27B1</italic>
###xml 184 191 180 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 270 271 266 267 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 377 384 373 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP27B1</italic>
###xml 389 396 385 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 810 813 806 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VDR</italic>
###xml 839 846 835 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP27B1</italic>
###xml 906 913 902 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 1361 1368 1357 1364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 1426 1434 1422 1430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 936 941 <span type="species:ncbi:9606">human</span>
###xml 1081 1086 <span type="species:ncbi:9606">human</span>
###xml 1147 1152 <span type="species:ncbi:10090">mouse</span>
Plasma concentrations of biologically active vitamin D (1,25-(OH)2D) are tightly controlled via feedback regulation of renal 1alpha-hydroxylase (CYP27B1; positive) and 24-hydroxylase (CYP24A1; catabolic) enzymes. In pregnancy, this regulation is uncoupled, and 1,25-(OH)2D levels are significantly elevated, suggesting a role in pregnancy progression. Epigenetic regulation of CYP27B1 and CYP24A1 has previously been described in cell and animal models, and despite emerging evidence for a critical role of epigenetics in placentation generally, little is known about the regulation of enzymes modulating vitamin D homeostasis at the fetomaternal interface. In this study, we investigated the methylation status of genes regulating vitamin D bioavailability and activity in the placenta. No methylation of the VDR (vitamin D receptor) and CYP27B1 genes was found in any placental tissues. In contrast, the CYP24A1 gene is methylated in human placenta, purified cytotrophoblasts, and primary and cultured chorionic villus sampling tissue. No methylation was detected in any somatic human tissue tested. Methylation was also evident in marmoset and mouse placental tissue. All three genes were hypermethylated in choriocarcinoma cell lines, highlighting the role of vitamin D deregulation in this cancer. Gene expression analysis confirmed a reduced capacity for CYP24A1 induction with promoter methylation in primary cells and in vitro reporter analysis demonstrated that promoter methylation directly down-regulates basal promoter activity and abolishes vitamin D-mediated feedback activation. This study strongly suggests that epigenetic decoupling of vitamin D feedback catabolism plays an important role in maximizing active vitamin D bioavailability at the fetomaternal interface.
###end p 6
###begin p 7
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice-Final version full access.
###end p 7
###begin p 8
The on-line version of this article (available at ) contains supplemental Figs. 1 and 2.
###end p 8
###begin p 9
###xml 404 405 404 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
In eutherian mammals, proper fetal growth and development are dependent on the formation and function of the placenta. In combination with the maternal decidua, cells of the placenta (primarily trophoblasts) regulate the exchange of nutrients, growth factors, oxygen, and waste between maternal and fetal circulations. The placenta also protects the developing pregnancy from the maternal immune system (1).
###end p 9
###begin p 10
###xml 186 187 186 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref2">2</xref>
###xml 378 379 378 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 134 139 <span type="species:ncbi:9606">human</span>
###xml 298 303 <span type="species:ncbi:9606">human</span>
###xml 400 405 <span type="species:ncbi:9606">human</span>
Although mammalian placentas share a basic common function in modulating exchange at the fetomaternal interface, it is clear that the human placenta is unique in structure and function (2). Animal models may therefore be of limited value in fully dissecting processes underlying certain aspects of human pathologies, such as pre-eclampsia and gestational trophoblastic disease (3). An examination of human placentation is therefore critical in understanding its unique function and potential role in disease.
###end p 10
###begin p 11
###xml 52 53 52 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 55 56 55 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn4">4</xref>
###xml 237 238 237 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
###xml 239 240 239 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 289 290 289 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 291 292 291 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
The biologically active form of vitamin D (1,25-(OH)2D)4 is a potent secosteroid hormone. Its wide ranging actions include regulating calcium and phosphorus homeostasis, immune system modulation, cellular differentiation, and apoptosis (4-6). It also has potent antiproliferative effects (7-9). Vitamin D deficiency has been linked to several adverse pregnancy outcomes, including those associated with placental insufficiency (including pre-eclampsia) (10, 11).
###end p 11
###begin p 12
###xml 36 37 36 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 166 168 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 244 245 232 233 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 292 294 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 374 375 362 363 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 399 401 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 403 405 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 461 462 449 450 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 510 512 498 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 561 562 549 550 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 624 625 612 613 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 651 653 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
Although concentrations of 1,25-(OH)2D are low in the early embryo, circulating maternal levels are elevated (approximately2-fold) during pregnancy (reviewed in Ref. 12), and it is clear that a large proportion of maternal circulating 1,25-(OH)2D is derived from decidua and placental cells (13). There is inconsistent evidence regarding transplacental transfer of 1,25-(OH)2D from mother to fetus (14, 15), but it is clear that the immediate precursor, 25-(OH)2D, crosses from maternal to fetal circulations (16). At birth, fetal and maternal levels of 25-(OH)2D are comparable, and indirect measures suggest that 1,25-(OH)2D may also be correlated (17).
###end p 12
###begin p 13
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 185 186 185 186 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref20">20</xref>
###xml 339 340 339 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 585 593 585 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 763 765 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 767 769 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 820 821 820 821 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1000 1002 1000 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 1058 1059 1058 1059 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1109 1111 1109 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 1252 1259 1252 1259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP27B1</italic>
###xml 1370 1371 1362 1363 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1385 1386 1377 1378 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1479 1481 1471 1473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 1506 1507 1498 1499 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1554 1561 1546 1553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 1733 1734 1725 1726 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1747 1748 1739 1740 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1751 1753 1743 1745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
###xml 1754 1756 1746 1748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 1763 1770 1755 1762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 1880 1882 1872 1874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 1956 1957 1948 1949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
###xml 1999 2006 1991 1998 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 2186 2188 2178 2180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref30">30</xref>
###xml 2190 2192 2182 2184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 70 75 <span type="species:ncbi:9606">human</span>
###xml 396 401 <span type="species:ncbi:9606">human</span>
###xml 429 434 <span type="species:ncbi:9606">human</span>
###xml 689 694 <span type="species:ncbi:9606">human</span>
###xml 893 898 <span type="species:ncbi:9606">human</span>
###xml 2143 2147 <span type="species:ncbi:10090">mice</span>
###xml 2152 2155 <span type="species:ncbi:10116">rat</span>
Several components of the vitamin D pathway are strongly expressed in human uterine decidua and placental tissues from early pregnancy (18, 19). VDR (vitamin D receptor)-bound 1,25-(OH)2D regulates key target genes associated with implantation and trophoblast functioning (including specific cytokines and homeobox genes (18-20). 1,25-(OH)2D has been shown to directly modulate the production of human chorioric gonadotrophin in human trophoblasts, and reduced expression and activity of 1-hydroxylase has been reported in differentiating trophoblast cells undergoing syncitialization in vitro (18). A supportive role of vitamin D in placental function is also evident by its influence on human placental lactogen, estradiol, and progesterone gene transcription (21, 22). In addition, vitamin D, in the form of 1,25-(OH)2D can function as an intracrine regulator of antibacterial responses in human trophoblasts that may lead to a novel mode of activation of innate immune responses in the placenta (23). Given its potent immunosuppressive effects, 1,25-(OH)2D may also play a role in implantation tolerance (19). The vitamin D metabolic pathway involves multiple enzymatic reactions, each of which is a potential target for epigenetic regulation. The CYP27B1 (1alpha-hydroxylase) gene product, 1alpha-hydroxylase, is directly responsible for the production of 1,25-(OH)2D from 25-(OH)2D. Largely expressed in the kidney, it is also expressed in decidual cells and the placenta (24). In contrast, 1,25-(OH)2D-hydroxylase (24-hydroxylase), encoded by the CYP24A1 (vitamin D 24-hydroxylase) gene, plays a pivotal role in the attenuation of vitamin D responsiveness by catalyzing synthesis of less active metabolites from both 1,25-(OH)2D and 25-(OH)2D (25-28). The CYP24A1 gene is up-regulated in several cancer cell types, where it attenuates vitamin D-mediated growth inhibition (29). However, other cancers appear to show decreased activity of this gene (4). Interestingly, a lack of expression of CYP24A1 has been directly associated with DNA methylation of the upstream promoter and first exon regions in tumor-derived endothelial cells in mice and rat osteoblastic ROS17/2.8 cells (30, 31).
###end p 13
###begin p 14
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref33">33</xref>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref34">34</xref>
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref35">35</xref>
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
The importance of epigenetic regulation in placental development and function is becoming increasingly apparent. General disruption of DNA methylation using drug treatment has been shown to disrupt placental development and also inhibit invasiveness in trophoblast cell models (32, 33). In addition to the well documented parent-of-origin specific imprinting of genes in the placenta (reviewed in Ref. 34), specific epigenetic silencing of nonimprinted genes has also recently been reported (35-38). This is likely to play a role in many aspects of placental functioning.
###end p 14
###begin p 15
###xml 168 169 168 169 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 375 380 <span type="species:ncbi:9606">human</span>
Very little is known about the epigenetic regulation of enzymes modulating vitamin D homeostasis at the fetomaternal interface. Given the likely importance of 1,25-(OH)2Din proper placental development and functioning, fetal development, and the modulation of maternal immune response to the developing fetus, we investigated epigenetic regulation of vitamin D metabolism in human placental tissue in general and in specific cell subtypes.
###end p 15
###begin title 16
EXPERIMENTAL PROCEDURES
###end title 16
###begin p 17
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tissue Isolation</italic>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref37">37</xref>
###xml 85 90 <span type="species:ncbi:9606">Human</span>
###xml 131 136 <span type="species:ncbi:9606">Women</span>
###xml 176 181 <span type="species:ncbi:9606">Women</span>
###xml 232 237 <span type="species:ncbi:9606">human</span>
Tissue Isolation-Tissues were collected for research purposes with approval from the Human Research Ethics Committees at the Royal Women's Hospital (03/51), Mercy Hospital for Women (R07/15), and Monash Medical Centre (07084C). For human placental tissue sampling, a core of full-thickness tissue was isolated from two randomly chosen sites. Tissue sections from other species were washed briefly in saline before processing by maceration with a scalpel blade prior to immediate DNA isolation. CVS samples were collected and processed as previously described (37).
###end p 17
###begin p 18
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref39">39</xref>
###xml 16 21 <span type="species:ncbi:9606">human</span>
###xml 606 611 <span type="species:ncbi:9796">horse</span>
###xml 617 622 <span type="species:ncbi:10090">mouse</span>
First trimester human cytotrophoblast cells were isolated as per Ref. 39, and purity of preparations was determined using antibodies to the trophoblast-specific cytokeratin-7 (1:100 dilution, clone OV-TL 12/30; DakoCytomation, Glostrup, Denmark) using immunocytochemistry. Cells were fixed in ethanol, rehydrated, and treated with 0.3% hydrogen peroxide in methanol for 10 min to block endogenous peroxidase activity. Cells were then washed with Tris-buffered saline and incubated with nonimmune block for 30 min. Primary antibody was applied and incubated at 48 degreesC for 16 h followed by biotinylated horse anti-mouse IgG (1:200) for 30 min and then streptavidinbiotin-peroxidase complex ABC (DakoCytomation) according to the manufacturer's instructions. Peroxidase activity was visualized by application of diaminobenzidine substrate (DakoCytomation) for 3-5 min. Cells were counterstained with Harris hematoxylin (Sigma), air-dried, and mounted. Only cell preparations in which 95% of the cells were positive for cytokeratin-7 were used for subsequent experiments.
###end p 18
###begin p 19
###xml 597 598 573 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 838 839 807 808 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
For CVS samples (8-10 weeks of gestation), contaminating maternal blood and decidua were removed, and approximately5-10 mg of cleaned villi was separated from the diagnostic sample, washed in isotonic saline, pelleted by centrifugation, and stored at -20 degreesC until DNA extraction and bisulfite modification. A cell culture from each villi sample was established by finely macerating the villi and resuspending in 1.0 ml of 0.25% trypsin with incubation of the suspension at 37 degreesC for 45 min. Cells were then resuspended in 7 ml of RPMI 1640 medium (SAFC Biosciences), pelleted at 560 x g, and resuspended in a small volume of AmnioMAX medium (Invitrogen) containing 0.5 mug/ml amphotericin B. The cell suspension was then inoculated onto glass coverslips in 35-mm Petri dishes with subsequent incubation at 37 degreesC in 5% CO2 in humidified air. Wells were then flooded with 2 ml of AmnioMAX medium the following day and were grown to around 95% confluence, trypsinized, pelleted, and stored at -20 degreesC until DNA extraction and bisulfite modification. Cultured cells were isolated following 14-18 days in culture with a maximum of three passages.
###end p 19
###begin p 20
###xml 0 31 0 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cell Culturing and Transfection</italic>
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref40">40</xref>
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref41">41</xref>
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref42">42</xref>
###xml 182 183 176 177 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 277 279 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref43">43</xref>
###xml 148 152 <span type="species:ncbi:9913">calf</span>
###xml 189 193 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Cell Culturing and Transfection-JEG-3 cells (HTB-36 (40)), BeWo (CCL-98 (41)), and JAR cells (HTB-144 (42)), were maintained in RPMI plus 10% fetal calf serum at 37 degreesC in 5% CO2. The SV40-transformed trophoblast HIPEC-65 cell line was maintained as previously described (43). Cells were grown for a minimal number of passages (<8) and were split (1:5-1:8) prior to confluence and harvesting of genomic DNA or transfection analysis.
###end p 20
###begin p 21
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 1.</label>
###xml 31 38 31 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 40 47 40 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP27B1</italic>
###xml 53 56 53 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VDR</italic>
###xml 9 80 9 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Methylation status of <italic>CYP24A1</italic>, <italic>CYP27B1</italic>, and <italic>VDR</italic> in human term placenta.</bold>
###xml 195 196 195 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 219 220 215 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 251 252 247 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 255 256 251 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 317 325 313 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gray box</italic>
###xml 339 350 335 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black boxes</italic>
###xml 366 371 362 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrow</italic>
###xml 399 401 395 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ii</italic>
###xml 526 537 522 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">parentheses</italic>
###xml 606 613 602 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Circles</italic>
###xml 636 667 632 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vertical dashes. Closed circles</italic>
###xml 682 694 678 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open circles</italic>
###xml 9 790 9 786 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="22"><bold>Methylation status of <italic>CYP24A1</italic>, <italic>CYP27B1</italic>, and <italic>VDR</italic> in human term placenta.</bold> Schematic representation of methylation data generated for regulatory regions of genes coding for 24-hydroxylase (<italic>A</italic>), 1&#945;-hydroxylase (<italic>B</italic>), and the vitamin D receptor (<italic>C</italic>). <italic>i</italic>, gene structure showing the location of methylation assays. <italic>Gray box</italic>, CpG island; <italic>black boxes</italic>, exon regions; <italic>arrow</italic>, translational start site. <italic>ii</italic>, mean methylation levels seen at each CpG site for each type of sample tested. Numbers of each type of tissue are listed in <italic>parentheses</italic>. Between 8 and 12 individual clones were sequenced for each sample. <italic>Circles</italic>, CpG sites denoted by <italic>vertical dashes. Closed circles</italic>, methylation; <italic>open circles</italic>, lack of methylation. Missing circles indicate CpG sites for which no information was obtained.</p>
###xml 9 790 9 786 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="22"><bold>Methylation status of <italic>CYP24A1</italic>, <italic>CYP27B1</italic>, and <italic>VDR</italic> in human term placenta.</bold> Schematic representation of methylation data generated for regulatory regions of genes coding for 24-hydroxylase (<italic>A</italic>), 1&#945;-hydroxylase (<italic>B</italic>), and the vitamin D receptor (<italic>C</italic>). <italic>i</italic>, gene structure showing the location of methylation assays. <italic>Gray box</italic>, CpG island; <italic>black boxes</italic>, exon regions; <italic>arrow</italic>, translational start site. <italic>ii</italic>, mean methylation levels seen at each CpG site for each type of sample tested. Numbers of each type of tissue are listed in <italic>parentheses</italic>. Between 8 and 12 individual clones were sequenced for each sample. <italic>Circles</italic>, CpG sites denoted by <italic>vertical dashes. Closed circles</italic>, methylation; <italic>open circles</italic>, lack of methylation. Missing circles indicate CpG sites for which no information was obtained.</p></caption>
###xml 790 790 786 786 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0210973730001"/>
###xml 0 790 0 786 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig1"><label>FIGURE 1.</label><caption><p textid="22"><bold>Methylation status of <italic>CYP24A1</italic>, <italic>CYP27B1</italic>, and <italic>VDR</italic> in human term placenta.</bold> Schematic representation of methylation data generated for regulatory regions of genes coding for 24-hydroxylase (<italic>A</italic>), 1&#945;-hydroxylase (<italic>B</italic>), and the vitamin D receptor (<italic>C</italic>). <italic>i</italic>, gene structure showing the location of methylation assays. <italic>Gray box</italic>, CpG island; <italic>black boxes</italic>, exon regions; <italic>arrow</italic>, translational start site. <italic>ii</italic>, mean methylation levels seen at each CpG site for each type of sample tested. Numbers of each type of tissue are listed in <italic>parentheses</italic>. Between 8 and 12 individual clones were sequenced for each sample. <italic>Circles</italic>, CpG sites denoted by <italic>vertical dashes. Closed circles</italic>, methylation; <italic>open circles</italic>, lack of methylation. Missing circles indicate CpG sites for which no information was obtained.</p></caption><graphic xlink:href="zbc0210973730001"/></fig>
###xml 60 65 <span type="species:ncbi:9606">human</span>
FIGURE 1.Methylation status of CYP24A1, CYP27B1, and VDR in human term placenta. Schematic representation of methylation data generated for regulatory regions of genes coding for 24-hydroxylase (A), 1alpha-hydroxylase (B), and the vitamin D receptor (C). i, gene structure showing the location of methylation assays. Gray box, CpG island; black boxes, exon regions; arrow, translational start site. ii, mean methylation levels seen at each CpG site for each type of sample tested. Numbers of each type of tissue are listed in parentheses. Between 8 and 12 individual clones were sequenced for each sample. Circles, CpG sites denoted by vertical dashes. Closed circles, methylation; open circles, lack of methylation. Missing circles indicate CpG sites for which no information was obtained.
###end p 21
###begin p 22
###xml 22 29 22 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 31 38 31 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP27B1</italic>
###xml 44 47 44 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VDR</italic>
###xml 0 71 0 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Methylation status of <italic>CYP24A1</italic>, <italic>CYP27B1</italic>, and <italic>VDR</italic> in human term placenta.</bold>
###xml 186 187 186 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 210 211 206 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 242 243 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 246 247 242 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 308 316 304 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gray box</italic>
###xml 330 341 326 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black boxes</italic>
###xml 357 362 353 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrow</italic>
###xml 390 392 386 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ii</italic>
###xml 517 528 513 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">parentheses</italic>
###xml 597 604 593 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Circles</italic>
###xml 627 658 623 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vertical dashes. Closed circles</italic>
###xml 673 685 669 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open circles</italic>
###xml 51 56 <span type="species:ncbi:9606">human</span>
Methylation status of CYP24A1, CYP27B1, and VDR in human term placenta. Schematic representation of methylation data generated for regulatory regions of genes coding for 24-hydroxylase (A), 1alpha-hydroxylase (B), and the vitamin D receptor (C). i, gene structure showing the location of methylation assays. Gray box, CpG island; black boxes, exon regions; arrow, translational start site. ii, mean methylation levels seen at each CpG site for each type of sample tested. Numbers of each type of tissue are listed in parentheses. Between 8 and 12 individual clones were sequenced for each sample. Circles, CpG sites denoted by vertical dashes. Closed circles, methylation; open circles, lack of methylation. Missing circles indicate CpG sites for which no information was obtained.
###end p 22
###begin p 23
###xml 47 48 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 268 275 268 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla</italic>
###xml 522 523 522 523 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 533 534 533 534 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 708 710 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref44">44</xref>
For transfection experiments, a total of 8 x 103 JAR or HIPEC65 cells were plated 24 h prior to transfection in each well of a 96-well plate (96F Nunclon Delta white microwell). Transfection was carried out using Lipofectamine LTX reagent (Invitrogen). Luciferase and Renilla activity was measured 24 h post-transfection using the DualGLO assay system (Promega, Madison, WI) on a FluorSTAR Optima microplate reader (BMG Labtech, Offenburg, Germany). For vitamin D induction experiments, cells were treated with 10 or 100 nm 1,25-(OH)2D (Sigma) 12 h post-transfection, with luciferase activity monitored after overnight incubation. Endometrial stromal cells and decidua were isolated as previously described (44).
###end p 23
###begin p 24
###xml 0 36 0 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Genomic DNA and Methylation Analysis</italic>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref37">37</xref>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
###xml 223 228 <span type="species:ncbi:9606">Human</span>
Genomic DNA and Methylation Analysis-Genomic DNA isolation and bisulfite DNA sequencing was performed as previously described (37, 38). DNA samples were processed using the Methyl Easytrade mark bisulfite modification kit (Human Genetic Signatures, Sydney, Australia) kit according to the manufacturer's instructions. Amplification was performed on converted genomic DNA using primers directed to bisulfite modified DNA: VDRbisF1, 5'-AATATTTTTTGTTCTTTAAGTGTTAAGTA; VDRbisF2, 5'-TAAATTTTAGTGTTTTTTAGTGTTTTAGTT; VDRBisR1, 5'-CTAACCTAATCAACCCAAATAAAAATA; CYP24BisF1, 5'-GGAAAGGGGGTTTTAAGAAATAGTA; CYP24BisR1, 5'-ACTTCCAACCCCAAAAAACTCTAAC; CYP24BisF2, 5'-TGGTTTTAGTTAGATTTTAGAGGTTAGTTT; CYP24BisR2, 5'-TACTATTTCTTAAAACCCCCTTTCC; CYP24BisF3, 5'-GAGTATGTTTTGGGTGGTTAATGAG; CYP24BisR3, 5'-TCCAAACTAAAAATATCTAACTCCCC; CYP27BisF1, 5'-TTTTGGTTGTTTTATATTTGTTTTG; CYP27BisR1, 5'-AACCATAACCCAAACCCTCAAATA.
###end p 24
###begin p 25
###xml 493 495 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref45">45</xref>
###xml 545 547 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref46">46</xref>
###xml 108 113 <span type="species:ncbi:10090">Mouse</span>
Marmoset amplification primers were marF1 (5'-GTATTTTAGGGAAGGTTTGGAG) and marR1 (5'-CCTCCTTCCTACAACAACAAC). Mouse primers were mF1 (5'-TGTTTAGTAGTGGTTAGTTGGTGGG) and mR1 (5'-ACATCCCTAAACATCTACCTCTTCC). Amplification conditions were as follows: 95 degreesC for 5 min, 56 degreesC for 1 min 30 s, and 72 degreesC for 1 min 30 s x 40 cycles, 72 degreesC for 7 min. Resulting amplicons were cloned into TOPO TA Cloning Vector (Invitrogen) for automated fluorescent sequencing as described in Ref. 45. Data were analyzed using BiQ Analyser software (46), and clones showing less than 80% conversion or that were identified as clonal in origin were not included in subsequent analysis. Mean methylation levels for each amplicon were determined using the formula (number of methylated CpG sites/total CpG sites examined x 100).
###end p 25
###begin p 26
###xml 0 28 0 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1 Gene Reporter Assays</italic>
###xml 81 88 81 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref47">47</xref>
###xml 640 648 640 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 903 910 903 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 1011 1014 1011 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pRn</italic>
###xml 1046 1053 1046 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla</italic>
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 817 821 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
CYP24A1 Gene Reporter Assays-A 758-bp region of the promoter/exon 1 of the human CYP24A1 gene previously shown to confer vitamin D responsiveness (47) was amplified using primers; Sal_CYP24_-548F (5'-CTCTCTGTCGACTTGGAGCTCCGCAGAAAGCCAAACTTCCT) and SalI_CYP24_+209R (5'-CTCTCTGTCGACGTACTCGAGACAGCCTCAGAGCATTGGTG) with Phusion Hi-Fidelity DNA polymerase (Finnzymes). The SalI-digested amplicon was cloned into a promoterless luciferase expression vector pGL3:basic (Promega, Madison, WI) to produce the plasmid pGL3:-594/+209. Reverse orientation cloning was also carried out to produce pGL:+209/-594. Following sequence verification, DNA was in vitro methylated using either Sss1, HpaII, or HhaI methylases (New England Biolabs, Ipswich, MA) according to the manufacturer's instructions. 100 ng of pGL3:control vector (SV40 constitutive promoter), pGL3:basic (promoterless), or unmethylated or methylated CYP24A1 promoter constructs were then transfected into JAR and HIPEC65 cells. Co-transfection with 10 ng of pRn (HSV-TK promoter linked to the Renilla luciferase gene) was carried out in all cases to normalize for transfection efficiency.
###end p 26
###begin p 27
###xml 0 26 0 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gene Induction Experiments</italic>
###xml 223 224 223 224 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 809 810 805 806 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 930 946 923 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1, CYP27B1</italic>
###xml 952 955 945 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VDR</italic>
###xml 1001 1006 994 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH</italic>
Gene Induction Experiments-24 h prior to induction, CVS-derived cells, skin, and placental-derived fibroblasts were seeded in a 6-well plate at a density of 250,000 cells/well. Half of the wells were then treated with 100 nm calcitriol (Sigma), and the other half were left untreated. Cells were then incubated for 7 h prior to total RNA isolation using TRIzol (Invitrogen) according to the manufacturer's instructions. cDNA synthesis was performed with the SuperScript III kit (Invitrogen), from 1 mug of total RNA. Quantitative reverse transcription-PCR was performed in a 96-well optical plate (Applied Biosystems, Foster City, CA) on a 7300 ABi thermal cycler (Applied Biosystems). The master mix consisted of 15 mul of Sybr Green Master Mix (Sigma), 1 mul of forward primer, 1 mul of reverse primer (50 pm final concentration), 8 mul of water, 5 mul of cDNA template in a total volume of 30 mul. Nondiluted cDNA was used for CYP24A1, CYP27B1, and VDR assays, and a 1:10 dilution was used for the GAPDH (glyceraldehyde-3-phosphate dehydrogenase) assay. Primer sequences were as follows: CYP24A1_F, 5'-CCCAAAGGAACAGTGCTCATG; CYP24A1_R, 5'-TCTCCTGAAGCCAACGTTCAG; CYP27B1_F, 5'-ATGAGGAACGGAGGACAGCC; CYP27B1_R, 5'-GAGCGTGTTGGACACCGTGT; VDR_F, 5'-TTGCGCTCCAATGAGTCCTTC; VDR_R, 5'-CTGTGTCCGGCTTTGGTCAC; GAPDH_F, 5'-TTCGACAGTCAGCCGCATCTT; GAPDH_R, 5'-CCCAATACGACCAAATCCGTT.
###end p 27
###begin title 28
RESULTS
###end title 28
###begin p 29
###xml 0 102 0 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">The CYP24A1 but Not the VDR or CYP27B1 Gene Promoter Is Methylated in Full Term Human Placental Tissue</italic>
###xml 297 309 297 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VDR, CYP24A1</italic>
###xml 315 322 315 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP27B1</italic>
###xml 349 352 349 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VDR</italic>
###xml 357 364 357 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 487 494 487 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP27B1</italic>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref48">48</xref>
###xml 582 584 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref49">49</xref>
###xml 677 680 677 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VDR</italic>
###xml 685 692 685 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP27B1</italic>
###xml 763 770 763 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 788 794 788 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 799 806 799 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 886 889 886 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VDR</italic>
###xml 894 901 894 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP27B1</italic>
###xml 992 999 992 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 1186 1193 1186 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 1318 1320 1318 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref50">50</xref>
###xml 1366 1373 1366 1373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 1461 1468 1461 1468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 1484 1491 1484 1491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 1657 1660 1657 1660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APC</italic>
###xml 1700 1702 1700 1702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref37">37</xref>
###xml 80 85 <span type="species:ncbi:9606">Human</span>
###xml 610 615 <span type="species:ncbi:9606">human</span>
The CYP24A1 but Not the VDR or CYP27B1 Gene Promoter Is Methylated in Full Term Human Placental Tissue-As a first step in the identification of potential epigenetic regulation of vitamin D levels in the placenta, we designed specific methylation amplification assays for regulatory regions of the VDR, CYP24A1, and CYP27B1 genes. In the case of the VDR and CYP24A1 genes, assays were designed to span the transcription start site and exon 1 within the associated CpG island, whereas for CYP27B1, we analyzed a region of exon 1 previously shown to be methylated in some cancers (48, 49). Initial experiments on human term placenta revealed a complete lack of methylation at the VDR and CYP27B1 gene regulatory regions, with clear (but variable) methylation of the CYP24A1 promoter region (Fig. 1 and Table 1). This was not due to problems with specific assays, since methylation of both VDR and CYP27B1 were detected in choriocarcinoma cells (see below). Three independent assays spanning the CYP24A1-associated CpG island were then examined with each showing evidence of methylation in full term placenta (supplemental Fig. 1). A total of 10 term placentas were then examined using the CYP24A1-2 assay spanning a region of differential methylation recently identified in the placenta by whole genome methylation data (50). These results confirmed methylation of the CYP24A1 CpG island in all full term placental samples, with a mean methylation level of 56.5% (Table 1). Whereas some CYP24A1 alleles showed nearly complete methylation, others were almost completely unmethylated. This is reminiscent of monoallelic methylation, previously described for the APC tumor suppressor gene in the placenta (37), but may equally reflect differing methylation profiles in a mixed population of cells.
###end p 29
###begin p 30
###xml 0 7 0 7 <label xmlns:xlink="http://www.w3.org/1999/xlink">TABLE 1</label>
###xml 43 59 43 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1, CYP27B1</italic>
###xml 65 68 65 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VDR</italic>
###xml 7 116 7 116 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Mean promoter methylation levels of <italic>CYP24A1, CYP27B1</italic>, and <italic>VDR</italic> genes in human placental samples and cell lines</bold>
###xml 7 116 7 116 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="31"><bold>Mean promoter methylation levels of <italic>CYP24A1, CYP27B1</italic>, and <italic>VDR</italic> genes in human placental samples and cell lines</bold></p>
###xml 116 969 116 969 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="32">A summary of CpG island methylation status for genes regulating vitamin D homeostasis and activity was determined by bisulfite sequencing. Placenta, full term placental tissue; 1st trimester CT, purified cytotrophoblasts showing &gt;95% CK-7 positive staining; Terminated pregnancy, placental tissue at 9&#8211;12 weeks gestation; Pre-eclampsia, diseased placental tissue at 9&#8211;12 weeks gestation; Choriocarcinoma, cell lines (BeWo, JEG-3, and/or JAR). Placental fibroblasts were isolated following serial passaging of Percoll gradient-separated cell fractions. Decidual cells, human endometrial stromal cells grown in culture. HIPEC65, an SV40-transformed trophoblast cell line. Normal tissue data consist of pooled data across a variety of different human tissues isolated from different subjects. The number of each type of cell/tissue is shown in parentheses.</p>
###xml 7 969 7 969 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="31"><bold>Mean promoter methylation levels of <italic>CYP24A1, CYP27B1</italic>, and <italic>VDR</italic> genes in human placental samples and cell lines</bold></p><p textid="32">A summary of CpG island methylation status for genes regulating vitamin D homeostasis and activity was determined by bisulfite sequencing. Placenta, full term placental tissue; 1st trimester CT, purified cytotrophoblasts showing &gt;95% CK-7 positive staining; Terminated pregnancy, placental tissue at 9&#8211;12 weeks gestation; Pre-eclampsia, diseased placental tissue at 9&#8211;12 weeks gestation; Choriocarcinoma, cell lines (BeWo, JEG-3, and/or JAR). Placental fibroblasts were isolated following serial passaging of Percoll gradient-separated cell fractions. Decidual cells, human endometrial stromal cells grown in culture. HIPEC65, an SV40-transformed trophoblast cell line. Normal tissue data consist of pooled data across a variety of different human tissues isolated from different subjects. The number of each type of cell/tissue is shown in parentheses.</p></caption>
###xml 969 973 969 973 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Gene</bold>
###xml 969 973 969 973 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Gene</bold></th>
###xml 973 979 973 979 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Tissue</bold>
###xml 973 979 973 979 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Tissue</bold></th>
###xml 979 995 979 995 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Mean methylation</bold>
###xml 979 995 979 995 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Mean methylation</bold></th>
###xml 995 1000 995 1000 <bold xmlns:xlink="http://www.w3.org/1999/xlink">S. D.</bold>
###xml 995 1000 995 1000 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>S. D.</bold></th>
###xml 969 1000 969 1000 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th colspan="1" rowspan="1" align="center" valign="top"><bold>Gene</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Tissue</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Mean methylation</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>S. D.</bold></th></tr>
###xml 969 1000 969 1000 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Gene</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Tissue</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Mean methylation</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>S. D.</bold></th></tr></thead>
###xml 1000 1000 1000 1000 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"/>
###xml 1000 1000 1000 1000 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"/>
###xml 1000 1001 1000 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink">%</italic>
###xml 1000 1001 1000 1001 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>%</italic></td>
###xml 1001 1001 1001 1001 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 1000 1001 1000 1001 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"><italic>%</italic></td><td colspan="1" rowspan="1" align="center" valign="top"/></tr>
###xml 1001 1008 1001 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 1001 1008 1001 1008 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"><italic>CYP24A1</italic></td>
###xml 1019 1020 1019 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1008 1026 1008 1026 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> Placenta (<italic>n</italic> = 8) </td>
###xml 1026 1033 1026 1033 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 56.53 </td>
###xml 1033 1040 1033 1040 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 10.49 </td>
###xml 1001 1040 1001 1040 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"><italic>CYP24A1</italic></td><td colspan="1" rowspan="1" align="left" valign="top"> Placenta (<italic>n</italic> = 8) </td><td colspan="1" rowspan="1" align="center" valign="top"> 56.53 </td><td colspan="1" rowspan="1" align="center" valign="top"> 10.49 </td></tr>
###xml 1040 1040 1040 1040 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"/>
###xml 1057 1058 1057 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1040 1064 1040 1064 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> Uncultured CVS (<italic>n</italic> = 4) </td>
###xml 1064 1071 1064 1071 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 33.07 </td>
###xml 1071 1077 1071 1077 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 9.31 </td>
###xml 1040 1077 1040 1077 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Uncultured CVS (<italic>n</italic> = 4) </td><td colspan="1" rowspan="1" align="center" valign="top"> 33.07 </td><td colspan="1" rowspan="1" align="center" valign="top"> 9.31 </td></tr>
###xml 1077 1077 1077 1077 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"/>
###xml 1092 1093 1092 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1077 1099 1077 1099 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> Cultured CVS (<italic>n</italic> = 4) </td>
###xml 1099 1106 1099 1106 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 33.79 </td>
###xml 1106 1113 1106 1113 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 19.02 </td>
###xml 1077 1113 1077 1113 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Cultured CVS (<italic>n</italic> = 4) </td><td colspan="1" rowspan="1" align="center" valign="top"> 33.79 </td><td colspan="1" rowspan="1" align="center" valign="top"> 19.02 </td></tr>
###xml 1113 1113 1113 1113 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"/>
###xml 1134 1135 1134 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1113 1141 1113 1141 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> First trimester CT (<italic>n</italic> = 4) </td>
###xml 1141 1148 1141 1148 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 48.17 </td>
###xml 1148 1155 1148 1155 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 24.49 </td>
###xml 1113 1155 1113 1155 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> First trimester CT (<italic>n</italic> = 4) </td><td colspan="1" rowspan="1" align="center" valign="top"> 48.17 </td><td colspan="1" rowspan="1" align="center" valign="top"> 24.49 </td></tr>
###xml 1155 1155 1155 1155 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"/>
###xml 1178 1179 1178 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1155 1185 1155 1185 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> Terminated pregnancy (<italic>n</italic> = 3) </td>
###xml 1185 1192 1185 1192 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 48.62 </td>
###xml 1192 1199 1192 1199 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 19.18 </td>
###xml 1155 1199 1155 1199 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Terminated pregnancy (<italic>n</italic> = 3) </td><td colspan="1" rowspan="1" align="center" valign="top"> 48.62 </td><td colspan="1" rowspan="1" align="center" valign="top"> 19.18 </td></tr>
###xml 1199 1199 1199 1199 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"/>
###xml 1215 1216 1215 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1199 1222 1199 1222 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> Pre-eclampsia (<italic>n</italic> = 3) </td>
###xml 1222 1229 1222 1229 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 39.85 </td>
###xml 1229 1235 1229 1235 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 6.32 </td>
###xml 1199 1235 1199 1235 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Pre-eclampsia (<italic>n</italic> = 3) </td><td colspan="1" rowspan="1" align="center" valign="top"> 39.85 </td><td colspan="1" rowspan="1" align="center" valign="top"> 6.32 </td></tr>
###xml 1235 1235 1235 1235 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"/>
###xml 1253 1254 1253 1254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1235 1260 1235 1260 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> Choriocarcinoma (<italic>n</italic> = 3) </td>
###xml 1260 1267 1260 1267 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 80.40 </td>
###xml 1267 1274 1267 1274 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 10.47 </td>
###xml 1235 1274 1235 1274 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Choriocarcinoma (<italic>n</italic> = 3) </td><td colspan="1" rowspan="1" align="center" valign="top"> 80.40 </td><td colspan="1" rowspan="1" align="center" valign="top"> 10.47 </td></tr>
###xml 1274 1274 1274 1274 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"/>
###xml 1297 1298 1297 1298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1274 1304 1274 1304 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> Placenta fibroblasts (<italic>n</italic> = 3) </td>
###xml 1304 1310 1304 1310 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 2.95 </td>
###xml 1310 1316 1310 1316 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 2.28 </td>
###xml 1274 1316 1274 1316 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Placenta fibroblasts (<italic>n</italic> = 3) </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.95 </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.28 </td></tr>
###xml 1316 1316 1316 1316 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"/>
###xml 1333 1334 1333 1334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1316 1340 1316 1340 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> Decidual cells (<italic>n</italic> = 4) </td>
###xml 1340 1346 1340 1346 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 1.57 </td>
###xml 1346 1352 1346 1352 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.57 </td>
###xml 1316 1352 1316 1352 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Decidual cells (<italic>n</italic> = 4) </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.57 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.57 </td></tr>
###xml 1352 1352 1352 1352 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"/>
###xml 1362 1363 1362 1363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1352 1369 1352 1369 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> HIPEC65 (<italic>n</italic> = 2) </td>
###xml 1369 1375 1369 1375 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 2.03 </td>
###xml 1375 1381 1375 1381 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.96 </td>
###xml 1352 1381 1352 1381 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> HIPEC65 (<italic>n</italic> = 2) </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.03 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.96 </td></tr>
###xml 1381 1381 1381 1381 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"/>
###xml 1403 1404 1403 1404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1381 1411 1381 1411 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> Nonplacental tissue (<italic>n</italic> = 10) </td>
###xml 1411 1417 1411 1417 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 1.56 </td>
###xml 1417 1423 1417 1423 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 1.12 </td>
###xml 1381 1423 1381 1423 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Nonplacental tissue (<italic>n</italic> = 10) </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.56 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.12 </td></tr>
###xml 1423 1430 1423 1430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP27B1</italic>
###xml 1423 1430 1423 1430 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"><italic>CYP27B1</italic></td>
###xml 1441 1442 1441 1442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1430 1448 1430 1448 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> Placenta (<italic>n</italic> = 4) </td>
###xml 1448 1454 1448 1454 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 5.23 </td>
###xml 1454 1460 1454 1460 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 4.88 </td>
###xml 1423 1460 1423 1460 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"><italic>CYP27B1</italic></td><td colspan="1" rowspan="1" align="left" valign="top"> Placenta (<italic>n</italic> = 4) </td><td colspan="1" rowspan="1" align="center" valign="top"> 5.23 </td><td colspan="1" rowspan="1" align="center" valign="top"> 4.88 </td></tr>
###xml 1460 1460 1460 1460 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"/>
###xml 1478 1479 1478 1479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1460 1485 1460 1485 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> Choriocarcinoma (<italic>n</italic> = 2) </td>
###xml 1485 1492 1485 1492 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 86.63 </td>
###xml 1492 1498 1492 1498 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 1.51 </td>
###xml 1460 1498 1460 1498 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Choriocarcinoma (<italic>n</italic> = 2) </td><td colspan="1" rowspan="1" align="center" valign="top"> 86.63 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.51 </td></tr>
###xml 1498 1501 1498 1501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VDR</italic>
###xml 1498 1501 1498 1501 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"><italic>VDR</italic></td>
###xml 1512 1513 1512 1513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1501 1519 1501 1519 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> Placenta (<italic>n</italic> = 2) </td>
###xml 1519 1525 1519 1525 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.65 </td>
###xml 1525 1531 1525 1531 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.14 </td>
###xml 1498 1531 1498 1531 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"><italic>VDR</italic></td><td colspan="1" rowspan="1" align="left" valign="top"> Placenta (<italic>n</italic> = 2) </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.65 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.14 </td></tr>
###xml 1531 1531 1531 1531 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"/>
###xml 1549 1550 1549 1550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1531 1556 1531 1556 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> Choriocarcinoma (<italic>n</italic> = 3) </td>
###xml 1556 1563 1556 1563 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 85.84 </td>
###xml 1563 1570 1563 1570 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 11.61 </td>
###xml 1531 1570 1531 1570 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Choriocarcinoma (<italic>n</italic> = 3) </td><td colspan="1" rowspan="1" align="center" valign="top"> 85.84 </td><td colspan="1" rowspan="1" align="center" valign="top"> 11.61 </td></tr>
###xml 1000 1570 1000 1570 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"><italic>%</italic></td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"><italic>CYP24A1</italic></td><td colspan="1" rowspan="1" align="left" valign="top"> Placenta (<italic>n</italic> = 8) </td><td colspan="1" rowspan="1" align="center" valign="top"> 56.53 </td><td colspan="1" rowspan="1" align="center" valign="top"> 10.49 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Uncultured CVS (<italic>n</italic> = 4) </td><td colspan="1" rowspan="1" align="center" valign="top"> 33.07 </td><td colspan="1" rowspan="1" align="center" valign="top"> 9.31 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Cultured CVS (<italic>n</italic> = 4) </td><td colspan="1" rowspan="1" align="center" valign="top"> 33.79 </td><td colspan="1" rowspan="1" align="center" valign="top"> 19.02 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> First trimester CT (<italic>n</italic> = 4) </td><td colspan="1" rowspan="1" align="center" valign="top"> 48.17 </td><td colspan="1" rowspan="1" align="center" valign="top"> 24.49 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Terminated pregnancy (<italic>n</italic> = 3) </td><td colspan="1" rowspan="1" align="center" valign="top"> 48.62 </td><td colspan="1" rowspan="1" align="center" valign="top"> 19.18 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Pre-eclampsia (<italic>n</italic> = 3) </td><td colspan="1" rowspan="1" align="center" valign="top"> 39.85 </td><td colspan="1" rowspan="1" align="center" valign="top"> 6.32 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Choriocarcinoma (<italic>n</italic> = 3) </td><td colspan="1" rowspan="1" align="center" valign="top"> 80.40 </td><td colspan="1" rowspan="1" align="center" valign="top"> 10.47 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Placenta fibroblasts (<italic>n</italic> = 3) </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.95 </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.28 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Decidual cells (<italic>n</italic> = 4) </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.57 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.57 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> HIPEC65 (<italic>n</italic> = 2) </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.03 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.96 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Nonplacental tissue (<italic>n</italic> = 10) </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.56 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.12 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"><italic>CYP27B1</italic></td><td colspan="1" rowspan="1" align="left" valign="top"> Placenta (<italic>n</italic> = 4) </td><td colspan="1" rowspan="1" align="center" valign="top"> 5.23 </td><td colspan="1" rowspan="1" align="center" valign="top"> 4.88 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Choriocarcinoma (<italic>n</italic> = 2) </td><td colspan="1" rowspan="1" align="center" valign="top"> 86.63 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.51 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"><italic>VDR</italic></td><td colspan="1" rowspan="1" align="left" valign="top"> Placenta (<italic>n</italic> = 2) </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.65 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.14 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Choriocarcinoma (<italic>n</italic> = 3) </td><td colspan="1" rowspan="1" align="center" valign="top"> 85.84 </td><td colspan="1" rowspan="1" align="center" valign="top"> 11.61 </td></tr></tbody>
###xml 969 1570 969 1570 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Gene</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Tissue</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Mean methylation</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>S. D.</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"><italic>%</italic></td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"><italic>CYP24A1</italic></td><td colspan="1" rowspan="1" align="left" valign="top"> Placenta (<italic>n</italic> = 8) </td><td colspan="1" rowspan="1" align="center" valign="top"> 56.53 </td><td colspan="1" rowspan="1" align="center" valign="top"> 10.49 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Uncultured CVS (<italic>n</italic> = 4) </td><td colspan="1" rowspan="1" align="center" valign="top"> 33.07 </td><td colspan="1" rowspan="1" align="center" valign="top"> 9.31 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Cultured CVS (<italic>n</italic> = 4) </td><td colspan="1" rowspan="1" align="center" valign="top"> 33.79 </td><td colspan="1" rowspan="1" align="center" valign="top"> 19.02 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> First trimester CT (<italic>n</italic> = 4) </td><td colspan="1" rowspan="1" align="center" valign="top"> 48.17 </td><td colspan="1" rowspan="1" align="center" valign="top"> 24.49 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Terminated pregnancy (<italic>n</italic> = 3) </td><td colspan="1" rowspan="1" align="center" valign="top"> 48.62 </td><td colspan="1" rowspan="1" align="center" valign="top"> 19.18 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Pre-eclampsia (<italic>n</italic> = 3) </td><td colspan="1" rowspan="1" align="center" valign="top"> 39.85 </td><td colspan="1" rowspan="1" align="center" valign="top"> 6.32 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Choriocarcinoma (<italic>n</italic> = 3) </td><td colspan="1" rowspan="1" align="center" valign="top"> 80.40 </td><td colspan="1" rowspan="1" align="center" valign="top"> 10.47 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Placenta fibroblasts (<italic>n</italic> = 3) </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.95 </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.28 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Decidual cells (<italic>n</italic> = 4) </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.57 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.57 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> HIPEC65 (<italic>n</italic> = 2) </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.03 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.96 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Nonplacental tissue (<italic>n</italic> = 10) </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.56 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.12 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"><italic>CYP27B1</italic></td><td colspan="1" rowspan="1" align="left" valign="top"> Placenta (<italic>n</italic> = 4) </td><td colspan="1" rowspan="1" align="center" valign="top"> 5.23 </td><td colspan="1" rowspan="1" align="center" valign="top"> 4.88 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Choriocarcinoma (<italic>n</italic> = 2) </td><td colspan="1" rowspan="1" align="center" valign="top"> 86.63 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.51 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"><italic>VDR</italic></td><td colspan="1" rowspan="1" align="left" valign="top"> Placenta (<italic>n</italic> = 2) </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.65 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.14 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Choriocarcinoma (<italic>n</italic> = 3) </td><td colspan="1" rowspan="1" align="center" valign="top"> 85.84 </td><td colspan="1" rowspan="1" align="center" valign="top"> 11.61 </td></tr></tbody></table>
###xml 0 1570 0 1570 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="tbl1"><label>TABLE 1</label><caption><p textid="31"><bold>Mean promoter methylation levels of <italic>CYP24A1, CYP27B1</italic>, and <italic>VDR</italic> genes in human placental samples and cell lines</bold></p><p textid="32">A summary of CpG island methylation status for genes regulating vitamin D homeostasis and activity was determined by bisulfite sequencing. Placenta, full term placental tissue; 1st trimester CT, purified cytotrophoblasts showing &gt;95% CK-7 positive staining; Terminated pregnancy, placental tissue at 9&#8211;12 weeks gestation; Pre-eclampsia, diseased placental tissue at 9&#8211;12 weeks gestation; Choriocarcinoma, cell lines (BeWo, JEG-3, and/or JAR). Placental fibroblasts were isolated following serial passaging of Percoll gradient-separated cell fractions. Decidual cells, human endometrial stromal cells grown in culture. HIPEC65, an SV40-transformed trophoblast cell line. Normal tissue data consist of pooled data across a variety of different human tissues isolated from different subjects. The number of each type of cell/tissue is shown in parentheses.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Gene</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Tissue</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Mean methylation</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>S. D.</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"><italic>%</italic></td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"><italic>CYP24A1</italic></td><td colspan="1" rowspan="1" align="left" valign="top"> Placenta (<italic>n</italic> = 8) </td><td colspan="1" rowspan="1" align="center" valign="top"> 56.53 </td><td colspan="1" rowspan="1" align="center" valign="top"> 10.49 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Uncultured CVS (<italic>n</italic> = 4) </td><td colspan="1" rowspan="1" align="center" valign="top"> 33.07 </td><td colspan="1" rowspan="1" align="center" valign="top"> 9.31 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Cultured CVS (<italic>n</italic> = 4) </td><td colspan="1" rowspan="1" align="center" valign="top"> 33.79 </td><td colspan="1" rowspan="1" align="center" valign="top"> 19.02 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> First trimester CT (<italic>n</italic> = 4) </td><td colspan="1" rowspan="1" align="center" valign="top"> 48.17 </td><td colspan="1" rowspan="1" align="center" valign="top"> 24.49 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Terminated pregnancy (<italic>n</italic> = 3) </td><td colspan="1" rowspan="1" align="center" valign="top"> 48.62 </td><td colspan="1" rowspan="1" align="center" valign="top"> 19.18 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Pre-eclampsia (<italic>n</italic> = 3) </td><td colspan="1" rowspan="1" align="center" valign="top"> 39.85 </td><td colspan="1" rowspan="1" align="center" valign="top"> 6.32 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Choriocarcinoma (<italic>n</italic> = 3) </td><td colspan="1" rowspan="1" align="center" valign="top"> 80.40 </td><td colspan="1" rowspan="1" align="center" valign="top"> 10.47 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Placenta fibroblasts (<italic>n</italic> = 3) </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.95 </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.28 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Decidual cells (<italic>n</italic> = 4) </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.57 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.57 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> HIPEC65 (<italic>n</italic> = 2) </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.03 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.96 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Nonplacental tissue (<italic>n</italic> = 10) </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.56 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.12 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"><italic>CYP27B1</italic></td><td colspan="1" rowspan="1" align="left" valign="top"> Placenta (<italic>n</italic> = 4) </td><td colspan="1" rowspan="1" align="center" valign="top"> 5.23 </td><td colspan="1" rowspan="1" align="center" valign="top"> 4.88 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Choriocarcinoma (<italic>n</italic> = 2) </td><td colspan="1" rowspan="1" align="center" valign="top"> 86.63 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.51 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"><italic>VDR</italic></td><td colspan="1" rowspan="1" align="left" valign="top"> Placenta (<italic>n</italic> = 2) </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.65 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.14 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="left" valign="top"> Choriocarcinoma (<italic>n</italic> = 3) </td><td colspan="1" rowspan="1" align="center" valign="top"> 85.84 </td><td colspan="1" rowspan="1" align="center" valign="top"> 11.61 </td></tr></tbody></table></table-wrap>
###xml 78 83 <span type="species:ncbi:9606">human</span>
###xml 684 689 <span type="species:ncbi:9606">human</span>
###xml 746 750 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 858 863 <span type="species:ncbi:9606">human</span>
TABLE 1Mean promoter methylation levels of CYP24A1, CYP27B1, and VDR genes in human placental samples and cell linesA summary of CpG island methylation status for genes regulating vitamin D homeostasis and activity was determined by bisulfite sequencing. Placenta, full term placental tissue; 1st trimester CT, purified cytotrophoblasts showing >95% CK-7 positive staining; Terminated pregnancy, placental tissue at 9-12 weeks gestation; Pre-eclampsia, diseased placental tissue at 9-12 weeks gestation; Choriocarcinoma, cell lines (BeWo, JEG-3, and/or JAR). Placental fibroblasts were isolated following serial passaging of Percoll gradient-separated cell fractions. Decidual cells, human endometrial stromal cells grown in culture. HIPEC65, an SV40-transformed trophoblast cell line. Normal tissue data consist of pooled data across a variety of different human tissues isolated from different subjects. The number of each type of cell/tissue is shown in parentheses.GeneTissueMean methylationS. D.%CYP24A1 Placenta (n = 8)  56.53  10.49  Uncultured CVS (n = 4)  33.07  9.31  Cultured CVS (n = 4)  33.79  19.02  First trimester CT (n = 4)  48.17  24.49  Terminated pregnancy (n = 3)  48.62  19.18  Pre-eclampsia (n = 3)  39.85  6.32  Choriocarcinoma (n = 3)  80.40  10.47  Placenta fibroblasts (n = 3)  2.95  2.28  Decidual cells (n = 4)  1.57  0.57  HIPEC65 (n = 2)  2.03  0.96  Nonplacental tissue (n = 10)  1.56  1.12 CYP27B1 Placenta (n = 4)  5.23  4.88  Choriocarcinoma (n = 2)  86.63  1.51 VDR Placenta (n = 2)  0.65  0.14  Choriocarcinoma (n = 3)  85.84  11.61
###end p 30
###begin p 31
###xml 36 52 36 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1, CYP27B1</italic>
###xml 58 61 58 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VDR</italic>
###xml 0 109 0 109 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Mean promoter methylation levels of <italic>CYP24A1, CYP27B1</italic>, and <italic>VDR</italic> genes in human placental samples and cell lines</bold>
###xml 71 76 <span type="species:ncbi:9606">human</span>
Mean promoter methylation levels of CYP24A1, CYP27B1, and VDR genes in human placental samples and cell lines
###end p 31
###begin p 32
###xml 568 573 <span type="species:ncbi:9606">human</span>
###xml 630 634 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 742 747 <span type="species:ncbi:9606">human</span>
A summary of CpG island methylation status for genes regulating vitamin D homeostasis and activity was determined by bisulfite sequencing. Placenta, full term placental tissue; 1st trimester CT, purified cytotrophoblasts showing >95% CK-7 positive staining; Terminated pregnancy, placental tissue at 9-12 weeks gestation; Pre-eclampsia, diseased placental tissue at 9-12 weeks gestation; Choriocarcinoma, cell lines (BeWo, JEG-3, and/or JAR). Placental fibroblasts were isolated following serial passaging of Percoll gradient-separated cell fractions. Decidual cells, human endometrial stromal cells grown in culture. HIPEC65, an SV40-transformed trophoblast cell line. Normal tissue data consist of pooled data across a variety of different human tissues isolated from different subjects. The number of each type of cell/tissue is shown in parentheses.
###end p 32
###begin p 33
###xml 0 78 0 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1 Placental Methylation in Multiple First Trimester Placental Cell Types</italic>
###xml 149 156 149 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 577 583 577 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 588 595 588 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 640 647 640 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 749 756 749 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 904 911 904 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 918 924 918 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 1160 1166 1160 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 1245 1252 1245 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 1104 1108 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
CYP24A1 Placental Methylation in Multiple First Trimester Placental Cell Types-In order to ascertain the cell types and timing of methylation of the CYP24A1 promoter within the placenta, we examined the methylation status of chorionic villous tissue (pre- and post-cell culturing), first trimester termination placental tissue, purified first trimester cytotrophoblasts (>90% cytokeratin-7-positive), and full term placental fibroblasts. Promoter methylation comparable with that seen in full term placental tissue was observed both in primary and cultured CVS tissue samples (Fig. 2 and Table 1) and in first trimester termination tissue (Table 1). Since the CVS culturing conditions do not favor trophoblast growth or division, the methylation of CYP24A1 seen in the cultured samples is probably mesodermal in origin. In addition, purified first trimester cytotrophoblasts also show methylation of the CYP24A1 gene (Fig. 2), demonstrating that this methylation is present in multiple cell types in first trimester placenta. No methylation was detected in purified full term placental fibroblasts or an SV40-transformed first trimester trophoblast cell line (Fig. 2). A summary of mean methylation levels obtained in this study is presented in Table 1.
###end p 33
###begin p 34
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 2.</label>
###xml 24 31 24 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 9 84 9 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Methylation of <italic>CYP24A1</italic> in different human placental tissues and cell types.</bold>
###xml 195 196 195 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 215 216 215 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 233 234 233 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 270 271 270 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 291 292 291 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 295 296 295 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 365 372 365 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Circles</italic>
###xml 395 426 395 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vertical dashes. Closed circles</italic>
###xml 441 453 441 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open circles</italic>
###xml 550 560 550 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gray boxes</italic>
###xml 587 593 587 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 636 646 636 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black line</italic>
###xml 649 651 649 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ii</italic>
###xml 776 787 776 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">parentheses</italic>
###xml 9 788 9 788 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="35"><bold>Methylation of <italic>CYP24A1</italic> in different human placental tissues and cell types.</bold> Representative methylation data generated for the CYP24A1-2 assay in cytokeratin-7 positive cytotrophoblasts (<italic>A</italic>), uncultured CVS (<italic>B</italic>), cultured CVS (<italic>C</italic>), full term placental fibroblasts (<italic>D</italic>), and whole blood (<italic>E</italic>). <italic>i</italic>, between 8 and 12 individual clones were sequenced for each sample. <italic>Circles</italic>, CpG sites denoted by <italic>vertical dashes. Closed circles</italic>, methylation; <italic>open circles</italic>, lack of methylation. Missing circles indicate CpG sites for which no information was obtained. <italic>Gray boxes</italic>, to GpG island locations; <italic>arrows</italic>, start site of translation within exon 1 (<italic>black line</italic>). <italic>ii</italic>, mean methylation levels seen at each CpG site for each type of sample tested. Numbers of each type of tissue are listed in <italic>parentheses</italic>.</p>
###xml 9 788 9 788 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="35"><bold>Methylation of <italic>CYP24A1</italic> in different human placental tissues and cell types.</bold> Representative methylation data generated for the CYP24A1-2 assay in cytokeratin-7 positive cytotrophoblasts (<italic>A</italic>), uncultured CVS (<italic>B</italic>), cultured CVS (<italic>C</italic>), full term placental fibroblasts (<italic>D</italic>), and whole blood (<italic>E</italic>). <italic>i</italic>, between 8 and 12 individual clones were sequenced for each sample. <italic>Circles</italic>, CpG sites denoted by <italic>vertical dashes. Closed circles</italic>, methylation; <italic>open circles</italic>, lack of methylation. Missing circles indicate CpG sites for which no information was obtained. <italic>Gray boxes</italic>, to GpG island locations; <italic>arrows</italic>, start site of translation within exon 1 (<italic>black line</italic>). <italic>ii</italic>, mean methylation levels seen at each CpG site for each type of sample tested. Numbers of each type of tissue are listed in <italic>parentheses</italic>.</p></caption>
###xml 788 788 788 788 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0210973730002"/>
###xml 0 788 0 788 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig2"><label>FIGURE 2.</label><caption><p textid="35"><bold>Methylation of <italic>CYP24A1</italic> in different human placental tissues and cell types.</bold> Representative methylation data generated for the CYP24A1-2 assay in cytokeratin-7 positive cytotrophoblasts (<italic>A</italic>), uncultured CVS (<italic>B</italic>), cultured CVS (<italic>C</italic>), full term placental fibroblasts (<italic>D</italic>), and whole blood (<italic>E</italic>). <italic>i</italic>, between 8 and 12 individual clones were sequenced for each sample. <italic>Circles</italic>, CpG sites denoted by <italic>vertical dashes. Closed circles</italic>, methylation; <italic>open circles</italic>, lack of methylation. Missing circles indicate CpG sites for which no information was obtained. <italic>Gray boxes</italic>, to GpG island locations; <italic>arrows</italic>, start site of translation within exon 1 (<italic>black line</italic>). <italic>ii</italic>, mean methylation levels seen at each CpG site for each type of sample tested. Numbers of each type of tissue are listed in <italic>parentheses</italic>.</p></caption><graphic xlink:href="zbc0210973730002"/></fig>
###xml 45 50 <span type="species:ncbi:9606">human</span>
FIGURE 2.Methylation of CYP24A1 in different human placental tissues and cell types. Representative methylation data generated for the CYP24A1-2 assay in cytokeratin-7 positive cytotrophoblasts (A), uncultured CVS (B), cultured CVS (C), full term placental fibroblasts (D), and whole blood (E). i, between 8 and 12 individual clones were sequenced for each sample. Circles, CpG sites denoted by vertical dashes. Closed circles, methylation; open circles, lack of methylation. Missing circles indicate CpG sites for which no information was obtained. Gray boxes, to GpG island locations; arrows, start site of translation within exon 1 (black line). ii, mean methylation levels seen at each CpG site for each type of sample tested. Numbers of each type of tissue are listed in parentheses.
###end p 34
###begin p 35
###xml 15 22 15 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 0 75 0 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Methylation of <italic>CYP24A1</italic> in different human placental tissues and cell types.</bold>
###xml 186 187 186 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 206 207 206 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 224 225 224 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 261 262 261 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 282 283 282 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 286 287 286 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 356 363 356 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Circles</italic>
###xml 386 417 386 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vertical dashes. Closed circles</italic>
###xml 432 444 432 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open circles</italic>
###xml 541 551 541 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gray boxes</italic>
###xml 578 584 578 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 627 637 627 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black line</italic>
###xml 640 642 640 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ii</italic>
###xml 767 778 767 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">parentheses</italic>
###xml 36 41 <span type="species:ncbi:9606">human</span>
Methylation of CYP24A1 in different human placental tissues and cell types. Representative methylation data generated for the CYP24A1-2 assay in cytokeratin-7 positive cytotrophoblasts (A), uncultured CVS (B), cultured CVS (C), full term placental fibroblasts (D), and whole blood (E). i, between 8 and 12 individual clones were sequenced for each sample. Circles, CpG sites denoted by vertical dashes. Closed circles, methylation; open circles, lack of methylation. Missing circles indicate CpG sites for which no information was obtained. Gray boxes, to GpG island locations; arrows, start site of translation within exon 1 (black line). ii, mean methylation levels seen at each CpG site for each type of sample tested. Numbers of each type of tissue are listed in parentheses.
###end p 35
###begin p 36
###xml 0 40 0 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1 Methylation Is Placenta-specific</italic>
###xml 301 308 301 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 570 576 570 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 581 588 581 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 665 672 665 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 218 223 <span type="species:ncbi:9606">human</span>
###xml 328 333 <span type="species:ncbi:9606">human</span>
###xml 688 694 <span type="species:ncbi:9606">humans</span>
###xml 736 741 <span type="species:ncbi:9606">human</span>
CYP24A1 Methylation Is Placenta-specific-Given the importance of the 24-hydroxylase enzyme in regulating levels of active vitamin D, it is surprising how little is known about the epigenetic regulation of this gene in human tissues. In order to address this, we assessed the methylation status of the CYP24A1 gene in a panel of human tissues consisting of kidney, skeletal muscle, skin fibroblasts, brain (prefrontal cortex), sperm, whole blood, buccal mucosa, endometrial stroma, decidualized stroma, bone marrow, and umbilical cord tissue. The results, (summarized in Fig. 2 and Table 1; detailed in supplemental Fig. 2), demonstrate the specificity of placental CYP24A1 methylation in humans, with no evidence for methylation in any human somatic tissue tested.
###end p 36
###begin p 37
###xml 0 91 0 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">The CYP24A1 Gene Is Differentially Methylated in Full Term Placentas from Different Mammals</italic>
###xml 352 359 352 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 443 449 443 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 519 526 519 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 568 575 568 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 774 780 768 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 204 209 <span type="species:ncbi:9606">human</span>
###xml 295 300 <span type="species:ncbi:10090">mouse</span>
###xml 422 427 <span type="species:ncbi:10090">mouse</span>
###xml 513 518 <span type="species:ncbi:9606">human</span>
###xml 629 634 <span type="species:ncbi:10090">mouse</span>
###xml 726 731 <span type="species:ncbi:9606">human</span>
###xml 830 835 <span type="species:ncbi:10090">mouse</span>
The CYP24A1 Gene Is Differentially Methylated in Full Term Placentas from Different Mammals-In previous studies, we have demonstrated that some of the specific promoter methylation recently documented in human term placental tissue is present in primates but absent in E18 (day 18 of pregnancy) mouse placenta. We therefore examined methylation of the CYP24A1 gene promoter regions in full term placenta from marmoset and mouse E18 and E11.5 (Fig. 3). Assays were designed to span the region corresponding to the human CYP24A1-2 assay. This revealed varying levels of CYP24A1 methylation in both marmoset (mean 27 +/- 18.7%) and mouse (mean 35.1 +/- 4.5%) placental tissue with generally lower levels relative to that seen in human full term placentas (mean 56.5 +/- 10.5%; Fig. 3) Interestingly, less methylation was seen in E18 mouse placental tissue compared with E11.5 tissue (data not shown).
###end p 37
###begin p 38
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 3.</label>
###xml 28 35 28 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 9 91 9 91 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Variable levels of <italic>CYP24A1</italic> methylation in different mammalian full term placentas.</bold>
###xml 154 161 154 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 191 192 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 205 206 205 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 209 222 209 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i, gray boxes</italic>
###xml 246 252 246 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 284 295 284 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Black boxes</italic>
###xml 313 315 313 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ii</italic>
###xml 373 380 373 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Circles</italic>
###xml 403 431 403 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black dashes. Closed circles</italic>
###xml 446 458 446 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open circles</italic>
###xml 481 492 481 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shaded bars</italic>
###xml 9 571 9 571 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="39"><bold>Variable levels of <italic>CYP24A1</italic> methylation in different mammalian full term placentas.</bold> Representative methylation data were generated for homologous <italic>CYP24A1</italic> promoter region in marmoset (<italic>A</italic>) and mouse (<italic>B</italic>). <italic>i, gray boxes</italic>, GpG island locations; <italic>arrows</italic>, orientation of transcription. <italic>Black boxes</italic>, assay location. <italic>ii</italic>, eight individual clones were sequenced for each sample. <italic>Circles</italic>, CpG sites denoted by <italic>black dashes. Closed circles</italic>, methylation; <italic>open circles</italic>, lack of methylation. <italic>Shaded bars</italic>, mean methylation levels seen at each CpG site for each type of sample tested.</p>
###xml 9 571 9 571 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="39"><bold>Variable levels of <italic>CYP24A1</italic> methylation in different mammalian full term placentas.</bold> Representative methylation data were generated for homologous <italic>CYP24A1</italic> promoter region in marmoset (<italic>A</italic>) and mouse (<italic>B</italic>). <italic>i, gray boxes</italic>, GpG island locations; <italic>arrows</italic>, orientation of transcription. <italic>Black boxes</italic>, assay location. <italic>ii</italic>, eight individual clones were sequenced for each sample. <italic>Circles</italic>, CpG sites denoted by <italic>black dashes. Closed circles</italic>, methylation; <italic>open circles</italic>, lack of methylation. <italic>Shaded bars</italic>, mean methylation levels seen at each CpG site for each type of sample tested.</p></caption>
###xml 571 571 571 571 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0210973730003"/>
###xml 0 571 0 571 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig3"><label>FIGURE 3.</label><caption><p textid="39"><bold>Variable levels of <italic>CYP24A1</italic> methylation in different mammalian full term placentas.</bold> Representative methylation data were generated for homologous <italic>CYP24A1</italic> promoter region in marmoset (<italic>A</italic>) and mouse (<italic>B</italic>). <italic>i, gray boxes</italic>, GpG island locations; <italic>arrows</italic>, orientation of transcription. <italic>Black boxes</italic>, assay location. <italic>ii</italic>, eight individual clones were sequenced for each sample. <italic>Circles</italic>, CpG sites denoted by <italic>black dashes. Closed circles</italic>, methylation; <italic>open circles</italic>, lack of methylation. <italic>Shaded bars</italic>, mean methylation levels seen at each CpG site for each type of sample tested.</p></caption><graphic xlink:href="zbc0210973730003"/></fig>
###xml 198 203 <span type="species:ncbi:10090">mouse</span>
FIGURE 3.Variable levels of CYP24A1 methylation in different mammalian full term placentas. Representative methylation data were generated for homologous CYP24A1 promoter region in marmoset (A) and mouse (B). i, gray boxes, GpG island locations; arrows, orientation of transcription. Black boxes, assay location. ii, eight individual clones were sequenced for each sample. Circles, CpG sites denoted by black dashes. Closed circles, methylation; open circles, lack of methylation. Shaded bars, mean methylation levels seen at each CpG site for each type of sample tested.
###end p 38
###begin p 39
###xml 19 26 19 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 0 82 0 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Variable levels of <italic>CYP24A1</italic> methylation in different mammalian full term placentas.</bold>
###xml 145 152 145 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 182 183 182 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 196 197 196 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 200 213 200 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i, gray boxes</italic>
###xml 237 243 237 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 275 286 275 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Black boxes</italic>
###xml 304 306 304 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ii</italic>
###xml 364 371 364 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Circles</italic>
###xml 394 422 394 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black dashes. Closed circles</italic>
###xml 437 449 437 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open circles</italic>
###xml 472 483 472 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Shaded bars</italic>
###xml 189 194 <span type="species:ncbi:10090">mouse</span>
Variable levels of CYP24A1 methylation in different mammalian full term placentas. Representative methylation data were generated for homologous CYP24A1 promoter region in marmoset (A) and mouse (B). i, gray boxes, GpG island locations; arrows, orientation of transcription. Black boxes, assay location. ii, eight individual clones were sequenced for each sample. Circles, CpG sites denoted by black dashes. Closed circles, methylation; open circles, lack of methylation. Shaded bars, mean methylation levels seen at each CpG site for each type of sample tested.
###end p 39
###begin p 40
###xml 0 124 0 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Methylation of the Core CYP24A1 Gene Promoter Directly Attenuates Basal Promoter Activity in Human Trophoblast-derived Cells</italic>
###xml 186 193 186 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 457 464 457 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref47">47</xref>
###xml 93 98 <span type="species:ncbi:9606">Human</span>
###xml 451 456 <span type="species:ncbi:9606">human</span>
Methylation of the Core CYP24A1 Gene Promoter Directly Attenuates Basal Promoter Activity in Human Trophoblast-derived Cells-Despite circumstantial evidence of an inverse correlation of CYP24A1 mRNA levels with promoter gene methylation (above), no direct evidence for DNA methylation-mediated silencing of this gene promoter has been reported. To investigate this further, we PCR-amplified the previously described vitamin D-responsive region of the human CYP24A1 gene promoter (47) and generated a luciferase reporter construct to directly test the effects of promoter methylation on both basal and vitamin D-induced promoter activity.
###end p 40
###begin p 41
###xml 198 206 198 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 375 381 375 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 523 524 511 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 552 553 540 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 858 859 846 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 877 878 865 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 897 898 885 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 972 973 960 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 4 8 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 21 26 <span type="species:ncbi:9606">human</span>
The SV40-transformed human trophoblast cell line, HIPEC65, and choriocarcinoma-derived JAR cells were transfected with two different reporter constructs (plus and minus orientation) with or without in vitro methylation with SssI or HpaII methylases. SssI methylase methylates all CpGs; HpaII methylase methylates only the CpG within the sequence CCGG. Results, summarized in Fig. 4, reveal a low level of promoter activity of this promoter region in the plus orientation in both cell lines, approximately6.5-fold (HIPEC65; p = 0.028) and 12-fold (JAR; p < 0.001) higher than that of the promoterless luciferase vector. Promoter activity in the reverse (minus) orientation was negligible (1.3-fold), demonstrating a directionality of the basal promoter element (data not shown). Basal activity was completely attenuated by prior methylation with any of SssI (p = 0.011), HpaII (p = 0.01), or HhaI (p = 0.014) methylases in HIPEC65 cells and inhibited in the JAR cell line (p < 0.001 for each of SssI and HpaII; supplemental Table 1). The 768-bp region of this gene used for reporter activity assays contains a total of 5 HhaI and 15 HpaII methylase target sites, suggesting that even low level methylation of this promoter is sufficient to abrogate gene expression activity.
###end p 41
###begin p 42
###xml 42 43 42 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 0 92 0 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CpG Island Methylation Abrogates 1,25-(OH)<sub>2</sub>D-mediated Up-regulation of CYP24A1 Transcription</italic>
###xml 167 174 167 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 340 341 340 341 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref47">47</xref>
###xml 555 556 555 556 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 566 567 566 567 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 643 644 643 644 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 790 791 790 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 835 843 835 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 905 911 905 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 923 924 923 924 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 985 986 985 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1043 1046 1043 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VDR</italic>
###xml 1137 1138 1137 1138 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
CpG Island Methylation Abrogates 1,25-(OH)2D-mediated Up-regulation of CYP24A1 Transcription-In addition to examining the effects of promoter methylation on the basal CYP24A1 promoter activity, we also set out to investigate the consequences of this methylation on the previously demonstrated inducibility of this gene promoter by 1,25-(OH)2D (47). JAR and HIPEC65 cells were transfected with the 768-bp core promoter with or without previous methylation with Sss1 methylase as above. 10 h post-transfection, one-half of cells were supplemented with 100 nm 1,25-(OH)2D, and reporter (luciferase) activity was then monitored. Although 1,25-(OH)2D treatment resulted in a clear induction (3.5-fold) of basal promoter activity in HIPEC65 cells in the absence of previous promoter methylation (p = 0.008), this response was abolished with in vitro methylation of the reporter construct prior to transfection (Fig. 4). 1,25-(OH)2D treatment had no effect on promoter activity in JAR cells (p = 0.663), most likely reflecting the methylation of the VDR gene in this cell line (see below) that silences the gene and inhibits exogenous 1,25-(OH)2D signaling through the VDR.
###end p 42
###begin p 43
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 4.</label>
###xml 9 67 9 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1 promoter activity in human trophoblast cell lines.</bold>
###xml 161 162 161 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 263 270 263 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref47">47</xref>
###xml 513 521 513 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 617 618 617 618 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 946 953 946 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla</italic>
###xml 1100 1110 1100 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Error bars</italic>
###xml 1251 1252 1251 1252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 9 1280 9 1280 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="44"><bold>CYP24A1 promoter activity in human trophoblast cell lines.</bold> SV40-transformed cytotrophoblast (HIPEC-65) or choriocarcinoma (JAR) cells were transfected (<italic>n</italic> = 8 for each cell line) with a promoterless luciferase reporter (vector) with or without the cloned <italic>CYP24A1</italic> gene promoter (&#8211;548/+209 relative to the start site of transcription). This region has previously been demonstrated to contain vitamin D-responsive elements (<xref ref-type="bibr" rid="ref47">47</xref>). Basal promoter activity was detected in both cell lines and was abolished with <italic>in vitro</italic> methylation of the promoter prior to transfection (Sss1, HpaII, and HhaI methylases). 1,25-(OH)<sub>2</sub>D (active vitamin D) induction of the promoter was observed only in HIPEC-65 cells (JAR cells are predicted to lack the vitamin D receptor, as evidenced by complete methylation of the associated CpG island), but this induction was attenuated with prior methylation of the promoter region. Luminescence values were normalized to <italic>Renilla</italic> luciferase to correct for transfection efficiency, and all data are displayed relative to the mean promoterless control vector in HIPEC-65 cells. <italic>Error bars</italic> denote 95% confidence intervals. Statistical analysis for comparing between transfected groups was carried out using a two-tailed Student's <italic>t</italic> test with unequal variance.</p>
###xml 9 1280 9 1280 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="44"><bold>CYP24A1 promoter activity in human trophoblast cell lines.</bold> SV40-transformed cytotrophoblast (HIPEC-65) or choriocarcinoma (JAR) cells were transfected (<italic>n</italic> = 8 for each cell line) with a promoterless luciferase reporter (vector) with or without the cloned <italic>CYP24A1</italic> gene promoter (&#8211;548/+209 relative to the start site of transcription). This region has previously been demonstrated to contain vitamin D-responsive elements (<xref ref-type="bibr" rid="ref47">47</xref>). Basal promoter activity was detected in both cell lines and was abolished with <italic>in vitro</italic> methylation of the promoter prior to transfection (Sss1, HpaII, and HhaI methylases). 1,25-(OH)<sub>2</sub>D (active vitamin D) induction of the promoter was observed only in HIPEC-65 cells (JAR cells are predicted to lack the vitamin D receptor, as evidenced by complete methylation of the associated CpG island), but this induction was attenuated with prior methylation of the promoter region. Luminescence values were normalized to <italic>Renilla</italic> luciferase to correct for transfection efficiency, and all data are displayed relative to the mean promoterless control vector in HIPEC-65 cells. <italic>Error bars</italic> denote 95% confidence intervals. Statistical analysis for comparing between transfected groups was carried out using a two-tailed Student's <italic>t</italic> test with unequal variance.</p></caption>
###xml 1280 1280 1280 1280 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0210973730004"/>
###xml 0 1280 0 1280 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig4"><label>FIGURE 4.</label><caption><p textid="44"><bold>CYP24A1 promoter activity in human trophoblast cell lines.</bold> SV40-transformed cytotrophoblast (HIPEC-65) or choriocarcinoma (JAR) cells were transfected (<italic>n</italic> = 8 for each cell line) with a promoterless luciferase reporter (vector) with or without the cloned <italic>CYP24A1</italic> gene promoter (&#8211;548/+209 relative to the start site of transcription). This region has previously been demonstrated to contain vitamin D-responsive elements (<xref ref-type="bibr" rid="ref47">47</xref>). Basal promoter activity was detected in both cell lines and was abolished with <italic>in vitro</italic> methylation of the promoter prior to transfection (Sss1, HpaII, and HhaI methylases). 1,25-(OH)<sub>2</sub>D (active vitamin D) induction of the promoter was observed only in HIPEC-65 cells (JAR cells are predicted to lack the vitamin D receptor, as evidenced by complete methylation of the associated CpG island), but this induction was attenuated with prior methylation of the promoter region. Luminescence values were normalized to <italic>Renilla</italic> luciferase to correct for transfection efficiency, and all data are displayed relative to the mean promoterless control vector in HIPEC-65 cells. <italic>Error bars</italic> denote 95% confidence intervals. Statistical analysis for comparing between transfected groups was carried out using a two-tailed Student's <italic>t</italic> test with unequal variance.</p></caption><graphic xlink:href="zbc0210973730004"/></fig>
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 68 72 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
FIGURE 4.CYP24A1 promoter activity in human trophoblast cell lines. SV40-transformed cytotrophoblast (HIPEC-65) or choriocarcinoma (JAR) cells were transfected (n = 8 for each cell line) with a promoterless luciferase reporter (vector) with or without the cloned CYP24A1 gene promoter (-548/+209 relative to the start site of transcription). This region has previously been demonstrated to contain vitamin D-responsive elements (47). Basal promoter activity was detected in both cell lines and was abolished with in vitro methylation of the promoter prior to transfection (Sss1, HpaII, and HhaI methylases). 1,25-(OH)2D (active vitamin D) induction of the promoter was observed only in HIPEC-65 cells (JAR cells are predicted to lack the vitamin D receptor, as evidenced by complete methylation of the associated CpG island), but this induction was attenuated with prior methylation of the promoter region. Luminescence values were normalized to Renilla luciferase to correct for transfection efficiency, and all data are displayed relative to the mean promoterless control vector in HIPEC-65 cells. Error bars denote 95% confidence intervals. Statistical analysis for comparing between transfected groups was carried out using a two-tailed Student's t test with unequal variance.
###end p 43
###begin p 44
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1 promoter activity in human trophoblast cell lines.</bold>
###xml 152 153 152 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 254 261 254 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref47">47</xref>
###xml 504 512 504 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 608 609 608 609 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 937 944 937 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla</italic>
###xml 1091 1101 1091 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Error bars</italic>
###xml 1242 1243 1242 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 59 63 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
CYP24A1 promoter activity in human trophoblast cell lines. SV40-transformed cytotrophoblast (HIPEC-65) or choriocarcinoma (JAR) cells were transfected (n = 8 for each cell line) with a promoterless luciferase reporter (vector) with or without the cloned CYP24A1 gene promoter (-548/+209 relative to the start site of transcription). This region has previously been demonstrated to contain vitamin D-responsive elements (47). Basal promoter activity was detected in both cell lines and was abolished with in vitro methylation of the promoter prior to transfection (Sss1, HpaII, and HhaI methylases). 1,25-(OH)2D (active vitamin D) induction of the promoter was observed only in HIPEC-65 cells (JAR cells are predicted to lack the vitamin D receptor, as evidenced by complete methylation of the associated CpG island), but this induction was attenuated with prior methylation of the promoter region. Luminescence values were normalized to Renilla luciferase to correct for transfection efficiency, and all data are displayed relative to the mean promoterless control vector in HIPEC-65 cells. Error bars denote 95% confidence intervals. Statistical analysis for comparing between transfected groups was carried out using a two-tailed Student's t test with unequal variance.
###end p 44
###begin p 45
###xml 83 99 83 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1, CYP27B1</italic>
###xml 105 108 105 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VDR</italic>
###xml 252 259 252 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 314 321 314 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 361 362 361 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 368 374 368 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref47">47</xref>
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref51">51</xref>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref52">52</xref>
###xml 504 505 504 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 617 618 605 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 968 974 944 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 1167 1173 1143 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
We also examined the effect of promoter methylation on the induction of endogenous CYP24A1, CYP27B1, and VDR gene expression in primary cells derived from CVS tissue (average methylation level of 33.4%) and placental and skin fibroblasts (both lacking CYP24A1 methylation). Cultured skin fibroblasts showed a mean CYP24A1 induction level approaching 2000-fold (n = 2; Fig. 5), consistent with previous data (47, 51, 52). Placental fibroblasts also showed a significant level of induction (mean 172-fold; n = 2). In contrast, cultured CVS cells showed a reduced capacity for gene induction (mean approximately10 fold; n = 4). In contrast to the major effects of vitamin D induction on CYP24A1 expression in skin and placental fibroblasts, VDR expression levels were slightly reduced (mean reduction of approximately3-fold) in skin fibroblasts, with little change apparent in placental fibroblasts (mean 1.18-fold increase) and CVS-derived cells (mean 0.76-fold change; Fig. 5). Similarly, no major effects on CYP27B1 expression level were seen in skin fibroblasts (mean 1.19-fold increase) or CVS-derived cells (mean 1.55-fold increase) following vitamin D induction (Fig. 5).
###end p 45
###begin p 46
###xml 0 79 0 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Altered CYP24A1 Methylation in Placental Tissue from Pre-eclampsia Pregnancies?</italic>
###xml 219 226 219 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 296 297 294 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 385 386 381 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 421 422 417 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Altered CYP24A1 Methylation in Placental Tissue from Pre-eclampsia Pregnancies?-We carried out a preliminary analysis of methylation levels of the CYP24A1-2 assay region in a small set of available preeclampsia tissue (Table 1). These samples showed a mean methylation level of only 39.5 +/- 6% (n = 3), compared with the 56.53 +/- 10% level seen in nonpre-eclampsia placental tissue (n = 8). The potential significance (p = 0.017) of these data will require further investigation in a larger sample size in the future.
###end p 46
###begin p 47
###xml 0 80 0 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Complete Methylation of Vitamin D Regulatory Genes in Choriocarcinoma Cell Lines</italic>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref53">53</xref>
###xml 414 416 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref54">54</xref>
Complete Methylation of Vitamin D Regulatory Genes in Choriocarcinoma Cell Lines-Trophoblast hyperplasia is a common feature of complete and partial hydatidiform mole with the potential for malignant transformation to choriocarcinoma (CCA) (53). Trophoblasts that comprise CCA resemble the primitive trophoblast of the previllous stage during placental development, arrested in specific stages of differentiation (54).
###end p 47
###begin p 48
###xml 38 45 38 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 147 154 147 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 210 216 210 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 271 278 271 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 371 374 371 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VDR</italic>
###xml 379 386 379 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP27B1</italic>
We analyzed the methylation status of CYP24A1 in three widely studied CCA cell lines, JEG-3, BeWo, and JAR. In all three lines, methylation at the CYP24A1 promoter was increased to nearly complete methylation (Fig. 6). These results correlate with the very low levels of CYP24A1 mRNA seen in each of these cell types (data not shown). We also assessed methylation at the VDR and CYP27B1 CpG islands, which also revealed nearly complete methylation of each of these genes in all cell lines tested. This contrasts with the complete lack of methylation seen in full term placental tissue and first trimester cytotrophoblast (described above).
###end p 48
###begin title 49
DISCUSSION
###end title 49
###begin p 50
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref55">55</xref>
###xml 240 241 240 241 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 467 468 467 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn5">5</xref>
###xml 513 516 513 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VDR</italic>
###xml 690 691 690 691 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 694 696 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 698 700 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref57">57</xref>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref58">58</xref>
###xml 730 737 730 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP27B1</italic>
###xml 850 852 850 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref57">57</xref>
###xml 921 922 921 922 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 817 825 <span type="species:ncbi:9606">patients</span>
Placental insufficiency, due to inadequate remodeling of the maternal vasculature in early pregnancy, is thought to play a major role in several adverse pregnancy outcomes, including the early stages of pre-eclampsia (55). Lowered 1,25-(OH)2D and altered calcium metabolism have been implicated in this process (10, 11). For example, a recent Cochrane review of randomized control trials demonstrated a role for calcium supplementation in reducing pre-eclampsia risk.5 Altered expression levels of 1-hydroxylase, VDR, and 24-hydroxylase genes have all been reported in different placental cells and tissue from preeclamptic pregnancies, possibly in response to decreasing maternal 1,25-(OH)2D (19, 57, 58). In addition, levels of CYP27B1 mRNA are reduced in cultured syncytial trophoblasts derived from pre-eclamptic patients compared with controls (57). These data highlight the likely functional importance of 1,25-(OH)2D in placental function and implicate disruption of vitamin D homeostasis in adverse pregnancy outcomes.
###end p 50
###begin p 51
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 5.</label>
###xml 9 72 9 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Induction of endogenous CYP24A1 mRNA in cultured primary cells.</bold>
###xml 121 122 121 122 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 132 133 132 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 134 135 134 135 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 310 311 310 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 351 356 351 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">table</italic>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref47">47</xref>
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref51">51</xref>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref52">52</xref>
###xml 749 759 737 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Error bars</italic>
###xml 792 794 780 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ND</italic>
###xml 9 814 9 802 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="52"><bold>Induction of endogenous CYP24A1 mRNA in cultured primary cells.</bold> Cells were cultured in multiple wells, and 100 n<sc>m</sc> 1,25-(OH)<sub>2</sub>D<sub>3</sub> (active vitamin D) was added to half of the cultures for 7 h, followed by total RNA isolation and quantitative real time reverse transcription-PCR. Mean levels of induction (<italic>n</italic> = 2&#8211;4) are listed in the corresponding <italic>table</italic>. Whereas cultured skin fibroblasts show a nearly 2000-fold induction of CYP24A1 expression, consistent with previous data (<xref ref-type="bibr" rid="ref47">47</xref>, <xref ref-type="bibr" rid="ref51">51</xref>, <xref ref-type="bibr" rid="ref52">52</xref>), and placental fibroblasts show a mean 172-fold induction, cultured CVS biopsies (containing cells with CYP24A1 methylation) show a greatly reduced level of gene induction (&#8764;10-fold). No major effects on VDR or CYP27B1 expression were observed. <italic>Error bars</italic> denote 95% confidence interval. <italic>ND</italic>, no data available.</p>
###xml 9 814 9 802 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="52"><bold>Induction of endogenous CYP24A1 mRNA in cultured primary cells.</bold> Cells were cultured in multiple wells, and 100 n<sc>m</sc> 1,25-(OH)<sub>2</sub>D<sub>3</sub> (active vitamin D) was added to half of the cultures for 7 h, followed by total RNA isolation and quantitative real time reverse transcription-PCR. Mean levels of induction (<italic>n</italic> = 2&#8211;4) are listed in the corresponding <italic>table</italic>. Whereas cultured skin fibroblasts show a nearly 2000-fold induction of CYP24A1 expression, consistent with previous data (<xref ref-type="bibr" rid="ref47">47</xref>, <xref ref-type="bibr" rid="ref51">51</xref>, <xref ref-type="bibr" rid="ref52">52</xref>), and placental fibroblasts show a mean 172-fold induction, cultured CVS biopsies (containing cells with CYP24A1 methylation) show a greatly reduced level of gene induction (&#8764;10-fold). No major effects on VDR or CYP27B1 expression were observed. <italic>Error bars</italic> denote 95% confidence interval. <italic>ND</italic>, no data available.</p></caption>
###xml 814 814 802 802 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0210973730005"/>
###xml 0 814 0 802 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig5"><label>FIGURE 5.</label><caption><p textid="52"><bold>Induction of endogenous CYP24A1 mRNA in cultured primary cells.</bold> Cells were cultured in multiple wells, and 100 n<sc>m</sc> 1,25-(OH)<sub>2</sub>D<sub>3</sub> (active vitamin D) was added to half of the cultures for 7 h, followed by total RNA isolation and quantitative real time reverse transcription-PCR. Mean levels of induction (<italic>n</italic> = 2&#8211;4) are listed in the corresponding <italic>table</italic>. Whereas cultured skin fibroblasts show a nearly 2000-fold induction of CYP24A1 expression, consistent with previous data (<xref ref-type="bibr" rid="ref47">47</xref>, <xref ref-type="bibr" rid="ref51">51</xref>, <xref ref-type="bibr" rid="ref52">52</xref>), and placental fibroblasts show a mean 172-fold induction, cultured CVS biopsies (containing cells with CYP24A1 methylation) show a greatly reduced level of gene induction (&#8764;10-fold). No major effects on VDR or CYP27B1 expression were observed. <italic>Error bars</italic> denote 95% confidence interval. <italic>ND</italic>, no data available.</p></caption><graphic xlink:href="zbc0210973730005"/></fig>
FIGURE 5.Induction of endogenous CYP24A1 mRNA in cultured primary cells. Cells were cultured in multiple wells, and 100 nm 1,25-(OH)2D3 (active vitamin D) was added to half of the cultures for 7 h, followed by total RNA isolation and quantitative real time reverse transcription-PCR. Mean levels of induction (n = 2-4) are listed in the corresponding table. Whereas cultured skin fibroblasts show a nearly 2000-fold induction of CYP24A1 expression, consistent with previous data (47, 51, 52), and placental fibroblasts show a mean 172-fold induction, cultured CVS biopsies (containing cells with CYP24A1 methylation) show a greatly reduced level of gene induction (approximately10-fold). No major effects on VDR or CYP27B1 expression were observed. Error bars denote 95% confidence interval. ND, no data available.
###end p 51
###begin p 52
###xml 0 63 0 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Induction of endogenous CYP24A1 mRNA in cultured primary cells.</bold>
###xml 112 113 112 113 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 123 124 123 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 125 126 125 126 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 301 302 301 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 342 347 342 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">table</italic>
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref47">47</xref>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref51">51</xref>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref52">52</xref>
###xml 740 750 728 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Error bars</italic>
###xml 783 785 771 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ND</italic>
Induction of endogenous CYP24A1 mRNA in cultured primary cells. Cells were cultured in multiple wells, and 100 nm 1,25-(OH)2D3 (active vitamin D) was added to half of the cultures for 7 h, followed by total RNA isolation and quantitative real time reverse transcription-PCR. Mean levels of induction (n = 2-4) are listed in the corresponding table. Whereas cultured skin fibroblasts show a nearly 2000-fold induction of CYP24A1 expression, consistent with previous data (47, 51, 52), and placental fibroblasts show a mean 172-fold induction, cultured CVS biopsies (containing cells with CYP24A1 methylation) show a greatly reduced level of gene induction (approximately10-fold). No major effects on VDR or CYP27B1 expression were observed. Error bars denote 95% confidence interval. ND, no data available.
###end p 52
###begin p 53
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref59">59</xref>
###xml 510 513 510 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VDR</italic>
###xml 517 524 517 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP27B1</italic>
###xml 765 767 761 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 769 771 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 773 775 769 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref60">60</xref>
###xml 829 836 825 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 912 913 904 905 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 926 927 918 919 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1245 1248 1237 1240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APC</italic>
###xml 1349 1351 1341 1343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref37">37</xref>
###xml 1361 1366 1353 1358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SFRP2</italic>
###xml 1472 1474 1464 1466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
###xml 534 539 <span type="species:ncbi:9606">human</span>
Epigenetic regulation of steroid signaling is an emerging field of research and hints at a complex interplay between environmental or dietary influences with underlying genetic variation, epigenetic variation, steroid metabolism, and subsequent downstream effects (59). However, at present, very little is known about the consequences of altered environmental, genetic, or epigenetic regulation of vitamin D homeostasis at the fetomaternal interface. In this study, we found no evidence for methylation of the VDR or CYP27B1 genes in human full term or first trimester placental tissue. Since methylation is generally associated with gene silencing, this supports previous data demonstrating high levels of expression of 1alpha-hydroxylase and VDR in the placenta (18, 19, 60). In contrast, we have identified methylation of the CYP24A1 gene, encoding 24alpha-hydroxylase, the major catabolic enzyme of 1,25-(OH)2D and 25-(OH)2D in placental tissue and cell subtypes. We have demonstrated that this methylation is present in both the trophoblast compartment and cells of mesodermal origin and is present (albeit at variable levels) in primate and rodent placentas. This contrasts with the recently described placenta-specific methylation of the APC tumor suppressor gene that is primate-specific and localizes solely to the trophoblast compartment (37) and the SFRP2 tumor suppressor methylation that is primate-specific but localizes to multiple placental cell subtypes (38).
###end p 53
###begin p 54
###xml 38 46 38 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 89 96 89 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 351 358 351 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 959 966 959 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 973 975 973 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref47">47</xref>
###xml 1049 1050 1049 1050 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1245 1247 1245 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref61">61</xref>
###xml 1273 1274 1273 1274 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1384 1385 1384 1385 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1441 1443 1441 1443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref62">62</xref>
###xml 1574 1575 1574 1575 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1575 1576 1575 1576 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 1618 1626 1618 1626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1680 1682 1680 1682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref63">63</xref>
###xml 1735 1736 1735 1736 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1803 1805 1799 1801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref64">64</xref>
###xml 384 389 <span type="species:ncbi:9606">human</span>
###xml 1459 1464 <span type="species:ncbi:9606">human</span>
###xml 1651 1656 <span type="species:ncbi:10090">mouse</span>
###xml 1705 1710 <span type="species:ncbi:9606">human</span>
Importantly, we have demonstrated (by in vitro reporter studies) that methylation of the CYP24A1 gene promoter directly down-regulates basal gene activity and abolishes vitamin D induction of the proximal promoter region. This is further supported by data demonstrating a reduced inducibility (by 2-3 orders of magnitude) of the methylated endogenous CYP24A1 gene in cultured primary human CVS-derived cells relative to unmethylated fibroblast cells. We observed much higher levels of induction of the endogenous gene in cultured primary fibroblast cells in comparison with that seen with a transfected reporter construct (containing only the proximal promoter region) in transformed trophoblast cells. This is consistent with previous data demonstrating a requirement for distal upstream sequence elements, in addition to the two previously described vitamin D-responsive elements, contained within the proximal promoter region, for maximal induction of the CYP24A1 gene (47). Interestingly, we did not find any major effects of exogenous 1,25-(OH)2D on the levels of VDR or CYP27B1 expression in skin or placental fibroblast cells. This contrasts with previous studies showing down-regulation of each of these genes in some cancer cell lines (61) in response to 1,25-(OH)2D treatment. In addition, the CYP27B1 gene was recently reported to be down-regulated in response to 1,25-(OH)2D in cultured trophoblasts undergoing syncitialization (62). The proximal human CYP27B1 gene promoter contains putative vitamin D-responsive elements and has been shown to mediate 1,25-(OH)2d-mediated down-regulation of this gene in in vitro reporter experiments in mouse proximal tubule cells (63). However, in primary human keratinocytes, 1,25-(OH)2D does not regulate 1alpha-hydroxylase mRNA or protein expression (64), supporting our findings in this study.
###end p 54
###begin p 55
###xml 57 64 57 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cyp24a1</italic>
###xml 199 200 199 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref30">30</xref>
###xml 339 340 339 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref30">30</xref>
###xml 438 445 438 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
###xml 277 282 <span type="species:ncbi:10090">mouse</span>
###xml 432 437 <span type="species:ncbi:9606">human</span>
Methylation of the proximal promoter region of the mouse Cyp24a1 gene has been previously reported in tumor-derived endothelial cells, where it contributes to selective growth inhibition by 1,25-(OH)2D (30). Conversely, a lack of methylation in corresponding non-tumor-derived mouse endothelial cells is associated with a lack of 1,25-(OH)2D-mediated growth inhibition (30). No equivalent data have previously been reported for the human CYP24A1 gene.
###end p 55
###begin p 56
###xml 57 58 57 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 187 188 175 176 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 234 236 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 307 308 295 296 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 483 490 471 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP27B1</italic>
###xml 580 581 564 565 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 693 694 677 678 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 736 743 720 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 796 797 780 781 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 917 919 901 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref65">65</xref>
###xml 920 922 904 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref67">67</xref>
###xml 938 945 922 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP27B1</italic>
###xml 1041 1043 1025 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 1045 1047 1029 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref68">68</xref>
###xml 1128 1129 1112 1113 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1208 1215 1192 1199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 1284 1285 1268 1269 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
It is well documented that maternal circulating 1,25-(OH)2D levels show a dramatic increase during pregnancy (reviewed in Ref. 12), with approximately50% of maternal circulating 1,25-(OH)2D derived from maternal decidua and placenta (13). This observation demonstrates that the tight regulation of 1,25-(OH)2D levels is uncoupled during pregnancy. There are two potential mechanisms by which this can be achieved. First, this can be achieved through an increase in expression of the CYP27B1 gene, which results in increasing 1alpha-hydroxylase and elevated production of 1,25-(OH)2D from less active precursors. The second potential mechanism involves a decrease in the catabolism of 1,25-(OH)2D by the 24-hydroxylase enzyme encoded by CYP24A1. Increasing levels of maternal circulating 1,25-(OH)2D during pregnancy have been linked to increased synthesis rather than decreasing catabolic activity in animal studies (65-67). In addition, CYP27B1 expression is increased in early pregnancy decidua in comparison with nonpregnant endometrium (19, 68). In this study, we have demonstrated that the increasing synthesis of 1,25-(OH)2D occurs in concert with a placenta-specific epigenetic down-regulation of the CYP24A1 (24-hydroxylase) gene. Thus, both mechanisms for elevating 1,25-(OH)2D levels are present during pregnancy.
###end p 56
###begin p 57
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 6.</label>
###xml 9 98 9 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Methylation analysis of vitamin D-associated genes in CCA-derived trophoblast cell lines.</bold>
###xml 149 152 149 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VDR</italic>
###xml 154 155 154 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 161 168 161 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP27B1</italic>
###xml 170 171 170 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 204 205 204 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 244 245 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 307 314 307 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 446 457 446 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">parentheses</italic>
###xml 526 533 526 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Circles</italic>
###xml 572 586 572 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Closed circles</italic>
###xml 601 613 601 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open circles</italic>
###xml 710 720 710 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gray boxes</italic>
###xml 761 767 761 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 816 826 816 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black line</italic>
###xml 829 832 829 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">iii</italic>
###xml 9 911 9 911 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="58"><bold>Methylation analysis of vitamin D-associated genes in CCA-derived trophoblast cell lines.</bold> High levels of methylation were detected for both <italic>VDR</italic> (<italic>A</italic>) and <italic>CYP27B1</italic> (<italic>C</italic>) in choriocarcinoma cell lines (<italic>n</italic> = 2). All choriocarcinoma cell lines (<italic>n</italic> = 3; BeWo not shown) examined showed hypermethylation of the <italic>CYP24A1</italic> gene relative to full term placental tissue or purified first trimester trophoblasts. Numbers of each type of tissue are listed in <italic>parentheses</italic>. Between 8 and 12 individual clones were sequenced for each sample. <italic>Circles</italic>, CpG sites within the assayed region. <italic>Closed circles</italic>, methylation; <italic>open circles</italic>, lack of methylation. Missing circles indicate CpG sites for which no information was obtained. <italic>Gray boxes</italic> correspond to GpG island locations, and <italic>arrows</italic> denote start site of translation within exon 1 (<italic>black line</italic>). <italic>iii</italic>, mean methylation levels seen at each CpG site for each type of sample tested.</p>
###xml 9 911 9 911 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="58"><bold>Methylation analysis of vitamin D-associated genes in CCA-derived trophoblast cell lines.</bold> High levels of methylation were detected for both <italic>VDR</italic> (<italic>A</italic>) and <italic>CYP27B1</italic> (<italic>C</italic>) in choriocarcinoma cell lines (<italic>n</italic> = 2). All choriocarcinoma cell lines (<italic>n</italic> = 3; BeWo not shown) examined showed hypermethylation of the <italic>CYP24A1</italic> gene relative to full term placental tissue or purified first trimester trophoblasts. Numbers of each type of tissue are listed in <italic>parentheses</italic>. Between 8 and 12 individual clones were sequenced for each sample. <italic>Circles</italic>, CpG sites within the assayed region. <italic>Closed circles</italic>, methylation; <italic>open circles</italic>, lack of methylation. Missing circles indicate CpG sites for which no information was obtained. <italic>Gray boxes</italic> correspond to GpG island locations, and <italic>arrows</italic> denote start site of translation within exon 1 (<italic>black line</italic>). <italic>iii</italic>, mean methylation levels seen at each CpG site for each type of sample tested.</p></caption>
###xml 911 911 911 911 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0210973730006"/>
###xml 0 911 0 911 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig6"><label>FIGURE 6.</label><caption><p textid="58"><bold>Methylation analysis of vitamin D-associated genes in CCA-derived trophoblast cell lines.</bold> High levels of methylation were detected for both <italic>VDR</italic> (<italic>A</italic>) and <italic>CYP27B1</italic> (<italic>C</italic>) in choriocarcinoma cell lines (<italic>n</italic> = 2). All choriocarcinoma cell lines (<italic>n</italic> = 3; BeWo not shown) examined showed hypermethylation of the <italic>CYP24A1</italic> gene relative to full term placental tissue or purified first trimester trophoblasts. Numbers of each type of tissue are listed in <italic>parentheses</italic>. Between 8 and 12 individual clones were sequenced for each sample. <italic>Circles</italic>, CpG sites within the assayed region. <italic>Closed circles</italic>, methylation; <italic>open circles</italic>, lack of methylation. Missing circles indicate CpG sites for which no information was obtained. <italic>Gray boxes</italic> correspond to GpG island locations, and <italic>arrows</italic> denote start site of translation within exon 1 (<italic>black line</italic>). <italic>iii</italic>, mean methylation levels seen at each CpG site for each type of sample tested.</p></caption><graphic xlink:href="zbc0210973730006"/></fig>
FIGURE 6.Methylation analysis of vitamin D-associated genes in CCA-derived trophoblast cell lines. High levels of methylation were detected for both VDR (A) and CYP27B1 (C) in choriocarcinoma cell lines (n = 2). All choriocarcinoma cell lines (n = 3; BeWo not shown) examined showed hypermethylation of the CYP24A1 gene relative to full term placental tissue or purified first trimester trophoblasts. Numbers of each type of tissue are listed in parentheses. Between 8 and 12 individual clones were sequenced for each sample. Circles, CpG sites within the assayed region. Closed circles, methylation; open circles, lack of methylation. Missing circles indicate CpG sites for which no information was obtained. Gray boxes correspond to GpG island locations, and arrows denote start site of translation within exon 1 (black line). iii, mean methylation levels seen at each CpG site for each type of sample tested.
###end p 57
###begin p 58
###xml 0 89 0 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Methylation analysis of vitamin D-associated genes in CCA-derived trophoblast cell lines.</bold>
###xml 140 143 140 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VDR</italic>
###xml 145 146 145 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 152 159 152 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP27B1</italic>
###xml 161 162 161 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 195 196 195 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 235 236 235 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 298 305 298 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 437 448 437 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">parentheses</italic>
###xml 517 524 517 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Circles</italic>
###xml 563 577 563 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Closed circles</italic>
###xml 592 604 592 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open circles</italic>
###xml 701 711 701 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gray boxes</italic>
###xml 752 758 752 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 807 817 807 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black line</italic>
###xml 820 823 820 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">iii</italic>
Methylation analysis of vitamin D-associated genes in CCA-derived trophoblast cell lines. High levels of methylation were detected for both VDR (A) and CYP27B1 (C) in choriocarcinoma cell lines (n = 2). All choriocarcinoma cell lines (n = 3; BeWo not shown) examined showed hypermethylation of the CYP24A1 gene relative to full term placental tissue or purified first trimester trophoblasts. Numbers of each type of tissue are listed in parentheses. Between 8 and 12 individual clones were sequenced for each sample. Circles, CpG sites within the assayed region. Closed circles, methylation; open circles, lack of methylation. Missing circles indicate CpG sites for which no information was obtained. Gray boxes correspond to GpG island locations, and arrows denote start site of translation within exon 1 (black line). iii, mean methylation levels seen at each CpG site for each type of sample tested.
###end p 58
###begin p 59
###xml 61 62 61 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 128 129 128 129 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 356 357 356 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 359 360 359 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref69">69</xref>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref71">71</xref>
We are currently investigating the specific role of 1,25-(OH)2D in mediating various aspects of placental functioning. 1,25-(OH)2D has widely diverse roles in regulating cell division, apoptosis, and immune modulation. It also shows antiproliferative effects in many different cell types, is proapoptotic, and is inhibitory to cell migration and invasion (5, 6, 69-71). Each of these processes plays an important role in the development and function of the mammalian placenta.
###end p 59
###begin p 60
###xml 59 71 59 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VDR, CYP24A1</italic>
###xml 77 84 77 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP27B1</italic>
###xml 188 191 188 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VDR</italic>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref72">72</xref>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref73">73</xref>
###xml 428 431 428 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VDR</italic>
###xml 436 443 436 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP27B1</italic>
###xml 549 556 549 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 708 715 708 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 804 807 804 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VDR</italic>
###xml 812 819 812 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP27B1</italic>
The interesting finding of simultaneous methylation of the VDR, CYP24A1, and CYP27B1 genes in choriocarcinoma-derived trophoblast cell lines is unprecedented in cancer. Methylation of the VDR gene is consistent with recent data demonstrating a lack of expression in BeWo and JEG-3 choriocarcinoma cell lines (72), and dysregulation of all three genes has been reported in cancers of different origin (73). Although abolition of VDR and CYP27B1 expression is anticipated to attenuate vitamin D-mediated growth inhibition in tumor cells, silencing of CYP24A1 would have the effect of maximizing active vitamin D bioavailability. It is possible that the precursor cells from which CCA developed already had the CYP24A1 methylation described in this study and that acquisition of epigenetic silencing of the VDR and CYP27B1 genes was associated with the development of this tumor type. It is interesting to speculate that a sequential series of methylation events may occur in tumor development and progression. Future studies examining the epigenetic regulation of this and other pathways in hydatidiform mole, recurring mole, and choriocarcinoma, may shed valuable light on the acquisition of methylation changes in gestational tumors.
###end p 60
###begin p 61
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref74">74</xref>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref75">75</xref>
###xml 421 422 421 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 752 754 752 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref76">76</xref>
###xml 755 757 755 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref83">83</xref>
###xml 798 800 798 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref84">84</xref>
###xml 801 803 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref89">89</xref>
###xml 854 861 854 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP24A1</italic>
###xml 909 911 909 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref56">56</xref>
Confirmation of epigenetic regulation of active vitamin D levels at the fetomaternal interface provides compelling circumstantial evidence for the intersection of two metabolic pathways in regulating pregnancy outcome, namely vitamin D and 1-carbon (folate or methyl donor) metabolism. One-carbon metabolism is a process by which methyl groups are passed from one donor molecule to the next (74, 75). This cycle produces S-adenosylmethionine, which donates its methyl group to cytosine to produce methylated CpG. Each of these pathways relies on external inputs for the production of precursor molecules, and enzymes involved in each pathway (including VDR and CYP27B1) have known functional polymorphic variants implicated in moderating disease risk (76-83), including adverse pregnancy outcomes (84-89). There are numerous polymorphisms throughout the CYP24A1 exonic, intronic, and regulatory gene regions (56), but as yet there is little information regarding the functionality or clinical relevance of such variants. The convergence/intersection of 1-carbon metabolism with other metabolic and signaling pathways is potentially very important in modulating disease risk and warrants further investigation.
###end p 61
###begin p 62
The placenta-specific epigenetic regulation of several genes and metabolic pathways, independent of well characterized imprinted regions, is now a firmly established phenomenon. Uncovering the mechanisms leading to the establishment of such markings, their timing, and sensitivity to environmental and genetic disruption has the potential to reveal valuable insights into the evolution of different placental functions and may reveal novel risk pathways associated with adverse pregnancy outcomes and tumor development.
###end p 62
###begin p 63
###xml 62 67 <span type="species:ncbi:9606">Women</span>
###xml 103 108 <span type="species:ncbi:9606">Women</span>
###xml 416 421 <span type="species:ncbi:10090">mouse</span>
###xml 465 470 <span type="species:ncbi:9606">human</span>
We thank Dr. Nicole Brooks and Tina Vaino (Mercy Hospital for Women, Australia) and Sarah Healy (Royal Women's Hospital) for help with collection of placental tissue, Professor Lois Salamonson (Prince Henry's Institute of Medical Research, Australia) and Professor Samuel Breit (University of NSW, Australia) for CCA cancer cell lines, Drs. Patrick Western and Craig Smith (Murdoch Childrens Research Institute) for mouse placental tissue, and Dr. Mark Pertile for human CVS samples. We especially thank Lavinia Gordon for bioinformatics help in this and previous studies.
###end p 63
###begin p 64
###xml 37 38 37 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 87 88 87 88 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 123 124 123 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 182 183 182 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 199 200 199 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
The abbreviations used are: 1,25-(OH)2D, biologically active form of vitamin D; 25-(OH)2D, immediate precursor of 1,25-(OH)2D; CVS, chorionic villus sampling; CCA, choriocarcinoma; En, embryonic day n.
###end p 64
###begin p 65
###xml 50 89 50 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cochrane Database of Systematic Reviews</italic>
###xml 89 91 89 91 <bold xmlns:xlink="http://www.w3.org/1999/xlink">3,</bold>
G. J. Hofmeyr, A. N. Atallah, and L. Duley (2006) Cochrane Database of Systematic Reviews3, CD001059, available on the World Wide Web.
###end p 65

